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INTRODUCTION
The population of older adults, aged 65 years and older, is rapidly increasing worldwide.(1) A 
growing population of older adults in number and an increasing life expectancy of individu-
als accounts for this change in societal balance.
Figure 1 shows the distribution of age in the Dutch population in the years 1990, 2014 and 
2040.(2) It makes clear nowadays the Dutch population has more people in the age of 70 and 
80 years as compared to 1990.
The bulge in this pyramid at 40 to 70 years will result in an obvious growth of the elderly in 
the next decades. Another way to clarify the demographic shift in the elderly population in 
the Netherlands is demonstrated in Figure 2.(2) The population of people aged 60-69 years 
remains relatively stable over the coming decades. However, there is a signifi cant increase in 
people aged 70-79 years and 80 years and over.
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Figure 1. Population pyramid of age distribution in the Netherlands in 1990, 2014 and 2040 respectively.
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Figure 2. Demographic shift in elderly population in the Netherlands.
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The consequences of these changes in age of population are enormous and cannot be 
overstressed. It will result in different social, economic and health-care related issues. So for 
example there will be an alteration in the ratio of working people to those depended and 
retired. Healthcare costs will increase due to a higher care demand of the elderly population.
(3) A relevant issue will be the attitude in medical decision-making related to the group of very 
old patients. To understand some potential healthcare problems that these changes entail, 
this thesis examined various surgical treatments and specific disorders of the elderly patient.
Nowadays, elderly patients are defined as patients aged 65 years and older.(4) In perspective 
of the fact that half of the girls born in 2013 are expected to reach the age of 100 years, it 
seems necessary to adapt this definition as perspectives are changing. It remains difficult to 
determine the age-threshold for the definition of “older people”, but shifting this definition to 
75 or 80 years and older seems justified.
To date, little is known about the outcome of surgical interventions in older people with 
respect to the quality of life and functional recovery. The success of surgical treatments in 
younger people may not be similar to the outcome of the same interventions in elderly 
people, Therefore, it remains to be determined whether the outcome of larger surgical in-
terventions for people aged above 65 years may be extrapolated to people aged above 75.
The prevalence of various operations for several diseases in the elderly is shown in table 1. 
These percentages are derived from the Amphia hospital, Breda, the Netherlands.
To determine the outcome of vascular and orthopaedic trauma surgery in the elderly, we 
initiated a number of studies focusing on vascular and trauma-related diseases. For vascular 
surgery we examined the outcome of different treatment options (e.g. endovascular vs. 
reconstructive surgery vs. conservative treatment) in different age groups with special atten-
tion for the results of conservative treatment. In critical limb ischemia, conservative treatment 
Table 1. Prevalence of operations (%) for several disorders according different age groups in the Amphia 
hospital, Breda, the Netherlands
Age Groups
<70 70-79 80+
Operation
Humerus fracture 56 % 17 % 27 % 
Femur fracture 28 % 22 % 50 % 
Critical limb ischemia 40 % 23 % 37 % 
AAA 26 % 60 % 14 % 
Data are presented as percentages
AAA=Abdominal aorta aneurysm
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was defi ned as adequate pain relief and wound care. Conservative treatment for abdominal 
aortic aneurysm implicated a wait and see policy without any surgical intervention.
Other studies were focused on traumatic lesions and the outcome of orthopaedic trauma 
surgery to determine the eff ect of treatment in the elderly population with regard tot the 
quality of life as well as functional result. Due to the increased life expectancy age-related 
problems are rising, including osteoporosis and falls.(5,6) Falls are the main cause of injuries 
among older adults, and leading to a high healthcare demand. It is open for discussion 
whether the benefi ts of recovery outweigh the high perioperative risks and the loss of daily 
function in the process of recovery and the length of rehabilitation. Quality of life is an in-
creasingly important indicator of treatment in elderly persons. Knowledge of the functional 
outcome as well as the eff ect of the intervention on daily life, in many cases already limited 
due to age-related problems may help in making the best choice in the management of 
these patients, considering the quality of life, health care costs and chance to maintain an 
independent lifestyle.
The goal of this thesis was to evaluate the health outcome measurements related to the 
surgical approach of vascular and orthopaedic trauma related diseases in older patients and 
to compare with younger patients.
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OUTLINE OF THIS THESIS
The aim of this thesis was to analyse health outcome measurements of surgical and conserva-
tive treatment for several vascular and orthopaedic trauma related diseases in the elderly 
patients. The thesis is outlined in two parts.
The first three studies describe the outcome of various aspects of vascular surgery in elderly 
patients. In chapter 2, we examine the preference for the anatomical location of arteriove-
nous fistulae in patients 75 years or older with primary and secondary outcome measure-
ments, defined as patency rates and mortality, respectively. In addition, a secondary outcome 
studied was the quality of life, an important component in dialysis patients influenced by 
many parameters. Chapter 3 presents the outcome of surgical interventions for critical limb 
ischemia in patients in different age groups (70-79 years and 80 years or older). Critical limb 
ischemia results in high morbidity and mortality and gives an increased risk of amputation 
when left untreated. To date, treatment of critical limb ischemia has shifted towards the in-
creasing use endovascular procedures, but results of various vascular therapies in especially 
the elderly are yet unknown. In the elderly the benefits of revascularization might be limited 
due to more comorbidities and short life expectancy. Therefore, optimal management of 
critical limb ischemia in the elderly is not straightforward and various treatment options are 
open for discussion. We compared different treatment options (conservative, endovascular, 
reconstructive surgery and amputation) and described survival, re-intervention rate and ma-
jor amputation rate. Chapter 4 describes the results of our study on the outcome of different 
surgical precedures to treat an abdominal aortic aneurysm (AAA) in patients aged 70 years 
and older. Optimal management of AAA in the elderly results in a risk assessment of their 
age, comorbidity, AAA size-related risk of rupture, functional and social status. This chapter 
includes a review of the literature concerning treatment of AAA in elderly patients.
The second part evaluates orthopaedic trauma surgery in elderly patients. Osteoporosis, 
falls and fractures are major public health issues among elderly. Pelvic fractures are associ-
ated with a serious morbidity and hospitalization rate. We therefore performed a study 
(chapter 5) to determine trends in incidence and age-specific rates of pelvic fracture related 
hospitalizations amongst elderly in the Netherlands. In Chapter 6 the results are described 
of an observational study analysing the outcome of operatively treated elderly patients (> 75 
years) with a fracture of the proximal humerus. The incidence of these fractures is increasing 
along with the increasing elderly population. With the advent of more advanced implants 
and improved surgical techniques, surgical interventions for these fractures are gaining more 
acceptances. Possible advantages include faster mobilization, less pain and better functional 
outcome. This is particularly true for younger patients.(7) However, the outcome of surgi-
cal treatment of these fractures in the elderly is not known yet. One of the most common 
fractures in the elderly is the proximal femoral fracture. Chapter 7 reports on the functional 
outcome and mortality rates after osteosynthesis of hip fractures in extremely old (≥90 years) 
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patients. This chapter focuses especially on the extremely elderly and discusses the question 
if a parameter or score can be defi ned that predicts the outcome of treatment within this 
population.
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PART I
OUTCOMES OF VARIOUS 
ASPECTS OF VASCULAR 
SURGERY IN ELDERLY 
PATIENTS

Chapter 2
Vascular access outcome in 
the elderly dialysis patient 
in combination with the 
Quality of Life
K. de Leur, Ç. Öztürk, M.L.P. van Zeeland, H.G.W. de Groot, 
J.M.M. Heyligers, P.W.H.E. Vriens, G.H. Ho, L. van der Laan
Vascular and Endovascular Surgery. 2013 Aug;47(6):444-8.
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ABSTRACT
Purpose: We performed a retrospective study on hemodialysis fistulae in patients aged 75 
years or older.
Methods: Dialysis records of 2 hospitals were searched for patients of 75 years or older who 
had primary autologous radiocephalic arteriovenous fistulae (RCAVFs) and brachiocephalic 
arteriovenous fistulae (BCAVFs). Outcome measures were primary, primary-assisted and 
secondary patency rates. Also, quality of life (QoL) was measured.
Results: A total of 107 fistulae were placed in 90 patients; 65 (61%) RCAVFs and 42 (39%) 
BCAVFs were created. The primary patency rate (p=0,026) and the primary-assisted patency 
rate (p=0,016) of BCAVFs were significantly higher than that of RCAVFs. Secondary patency 
rates at 1 year (p=0,01) and 2 years (p=0,035) were higher in BCAVFs than in RCAVFs.
Conclusions: The BCAVFs give significantly higher primary and primary-assisted patency rates 
and also significantly higher secondary patency rates at 1 and 2 years. Therefore, we suggest 
the placement of elbow fistulae in the elderly patients. The QoL was surprisingly high in this 
population despite a high mortality rate.  
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INTRODUCTION
The Dialysis Outcomes Quality Initiative (DOQI) recommends radiocephalic arteriovenous fi s-
tulae (RCAVFs) before brachiocephalic arteriovenous fi stulae (BCAVFs) in all dialysis patients 
needing hemodialysis (HD). When the placement of arteriovenous fi stulae (AVFs) is indicated 
for patients requiring HD, the primary creation site according to the DOQI should be in the 
nondominant limb and then in order of preference, radiocephalic, brachiocephalic and 
brachiobasillic.(1-3) There are several factors infl uencing the patency of AVFs such as smoking, 
obesity, diabetes, gender, and ethnicity and age.(1) Several studies reported mixed results in 
comparison to outcomes in RCAVFs and BCAVFs in elderly patients.(3,4)
In elderly patients, in need of HD, the patency rates of diff erent types of AVFs can be useful 
to make a decision about which type of AVF should be used. Weale et al described equivalent 
outcomes in RCAVFs and BCAVFs in patients ≥ 80 years.(3) The RCAVFs have a high functional 
failure rate compared to BCAVFs.(5) However, the RCAVFs are preferred to BCAVFs because fu-
ture access site options should be saved in the HD population. In elderly patients with lower 
life expectancy, a fi stula with higher primary patency rate and less reinterventions might be 
the preferable option, also when considering Quality of Life (QoL). Currently information on 
QoL in elderly HD patients is still lacking. However, this information is crucial in the choice of 
therapy in these patients.
The present study compares the outcome of autologous RCAVFs and BCAVFs in our institu-
tions in the HD population of 75 years and older and evaluates the QoL of the elderly HD 
patients.
METHODS
We consulted the institutional review board (AMOA) of the Amphia hospital, and they confi rmed 
that no formal written waiver for the need of ethics approval was required because of the 
retrospective design of the study. Also there was no written consent needed from the patients.
Trial design
The study was performed at the departments of surgery and dialysis of the Amphia hospital in 
Breda and St Elisabeth Hospital in Tilburg, the Netherlands. Dialysis and operating room records 
from 2001 through 2008 were reviewed to identify all patients of 75 years and older undergo-
ing a vascular access procedure for HD. Autogenous RCAVFs and BCAVFs were included in this 
study. Information about patient demographics, comorbidities, and previous dialysis access 
procedures was collected. Follow-up data were obtained from the hospital records.
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Work-up and surgical Procedure
Fistula placement was preferably performed in the most distal portion of the nondominant 
arm. Clinical judgment as well as preoperative duplex ultrasonography was used to assess 
vascular anatomy and to determine the diameters of the radial and brachial arteries and the 
cephalic vein with minimum acceptable threshold for internal diameters set at 2.0 mm.(6) The 
AVF procedures were autogenous RCAVFs and BCAVFs.
Definitions
The surgical procedure was considered successful if presence of a thrill on palpation and/or 
auscultation was determined the day after the operation. Primary patency or intervention-free 
access survival was defined as the interval between access placement until any intervention 
designed to maintain or reestablish patency, access thrombosis, or the time of measurement 
of patency.(7,8) Primary-assisted patency was defined as the interval between access place-
ment until any preemptive surgical or endovascular repair without access to thrombosis. 
Secondary patency was defined as the interval between access placement until access aban-
donment or the time of patency measurement including intervening manipulations (surgical 
or endovascular interventions) designed to re-establish functionality in thrombosed access.
(7,8) Primary failure or inadequate maturation was defined as an AVF that did not develop to 
maintain dialysis or thrombosed before the first successful cannulation for HD treatment, at 
6 weeks after surgery.(6,7) The AVFs that never matured were included in the patency rates.
QoL assessment
Patients were asked to fill out the World Health Organization Quality of Life assessment instru-
ment (WHOQOL-BREF), which is an abbreviated version of the original WHOQOL-100.(9,10) This 
questionnaire was sent to the patients in January 2010. The questionnaire consists of 26 ques-
tions, and 24 questions assess the domains physical health (7 questions), psychological health 
(6 questions), social relationships (3 questions) and environment (8 questions). Each question 
has a 5-point Likert scale. The other 2 questions assess Global QoL and general health. Instruc-
tions of the World Health Organization (WHO) scoring were used to calculate the various QoL 
domains.(11) Likert scale data were converted into raw domain scores of the 4 distinct domains 
and transformed on a range from 0 to 100 , with higher scores corresponding with a better 
QoL. Raw QoL domain scores of our population were compared with raw QoL domain scores of 
patients 3 months after peripheral bypass surgery in our institution as studied by Öztürk et al.(12)
Statistical analysis
The SPSS 18.0 for Windows package (SPSS Inc., Chicago, IL, USA) was used for the statistical 
analysis. Frequencies and descriptive statistics were used for reporting the baseline charac-
teristics of the patient group.
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Patency rates were transformed into a dichotomous outcome for specifi c time periods (1 
year and 2 years). Data of access sites were assessed to be either patent or thrombosed at the 
end of each time period. The number of outcome events is represented by the number of 
thrombosed fi stulae. Primary failures were included in the patency rates.
Patency rates were calculated with the Kaplan-Meier curves and the log-rank test was used 
to determine statistical signifi cance. A P-value below 0.05 was considered to denote statisti-
cal signifi cance. Dates of death were recorded. Patients who died or lost for follow up were 
censored for analysis. Descriptive analyses were used to calculate means and medians on 
each part of the QoL.
RESULTS
Baseline characteristics
From 2001 to 2008, a total of 107 permanent vascular accesses in 90 patients were recorded 
in the database. Mean age was 78 years (range 75-88) and 59 were males (66%). A total of 17 
(19%) patients received more than 1 AVF during this observation period. A total of 65 (61%) 
AVFs were created at the wrist and 42 (39%) AVFs at the elbow. A total of 58 (54%) fi stulae 
were actually used for dialysis, 41 (38%) fi stulae were never cannulated and 8 (8%) fi stulae 
dialysis records provided insuffi  cient information about its cannulation. Of the 41 fi stulae 
that were never used, in 9 cases the patient died, in 27 fi stulae there was primary failure, and 
in 5 cases HD never started. In the primary failure group, 4 fi stulae could not be cannulated 
because of inadequate maturation, 14 fi stulae were occluded before fi rst cannulation, 2 
fi stulae were abandoned because of steal; in 2 cases, cannulation was not successful and in 
5 cases, dialysis records only reported primary failure. Baseline characteristics of the 90 HD 
Table 1. Baseline characteristics
Characteristic
RCAVF
(N=65)
BCAVF
(N=42)
P value*
Age, years (range) 78 (75-88) 77 (75-84)
Male sex (%) 44 (68%) 26 (62%) 0,54
Coronary artery disease (%) 50 (77%) 31 (74%) 0,71
Peripheral vascular disease (%) 22 (34%) 16 (38%) 0,74
COPD (%) 19 (29%) 8 (19%) 0,22
Smoking (%) 17 (26%) 15 (36%) 0,35
Diabetes Mellitus (%) 22 (34%) 16 (38%) 0,74
BMI (range) 25 (16-41) 26 (19-34)
Values are depicted as percentages or as median with range.
BMI = body mass index.
*Calculated by chi-square test
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patients are shown in Table 1. There were no significant differences in gender and comorbidi-
ties between the RCAVF group and the BCAVF group.
Patency
Patency rates at 6 months, 1 year, and 2 years were determined. The results are shown in 
Table 2 and Figure 2-4. The primary patency rate (p=0,026) and the primary-assisted patency 
rate (p=0,016) of BCAVFs were significantly higher in comparison to RCAVFs. Also the second-
ary patency rates at 1 year (p=0,01) and 2 years (p=0,035) were significantly higher in BCAVFs, 
however secondary patency (p=0,14) rate was not significantly different between the groups. 
At the end of the study, 51 (57%) of 90 patients had died.
QoL analysis
Of the 90 patients included in this retrospective analysis, only 39 (43%) patients were alive 
in January 2010 and could be invited to participate in the QoL study, and 9 (23%) patients 
did not respond or failed to complete the questionnaire. Finally, data were available for 30 
patients; 8 in the BCAVF group and 22 in the RCAVF group. Summary statistics of the raw 
domain scores for all 30 patients are listed in Table 3. On the domain of Global QoL a score 
of 71 (median 71,5) was found on a scale of 0-100. Raw domain scores in these patients were 
relatively high compared to raw domain scores of patients after peripheral bypass surgery.(12)
Table 2. Primary (PP), assisted (AP) and secondary (SP) patency rates at 6 months, 1 and 2 year according 
to type of fistula
Patency RCAVF
(N=65)
BCAVF
(N=42)
P-value*
Primary patency rate (%) 0,026
 At 6 months 39 58 0,14 
 At 1 year 31 52 0,01 
 At 2 year 22 41 0,009 
Assisted patency rate (%) 0,016
 At 6 months 50 68 0,21 
 At 1 year 34 54 0,034 
 At 2 year 25 49 0,011 
Secondary patency rate (%) 0,14
 At 6 months 69 84 0,056 
 At 1 year 58 70 0,010 
 At 2 year 50 57 0.035 
*Calculated by log rank test
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Figure 1. Overall 3-years survival in total study population.
 
	  
Log rank ;  p; 0.026 
	  
65	  
42	  
2	  
2	  
8	  
3	  
17	  
11	  
Figure 2. Kaplan-Meier curve of primary patency rates of RCAVF and BCAVF.
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Figure 4. Kaplan-Meier curve of primary-assisted patency rates of RCAVF and BCAVF.
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Figure 3. Kaplan-Meier curve of secondary patency rates of RCAVF and BCAVF.
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DISCUSSION
According to demographic trends in the Netherlands, in the next 30 years the age category 
of 75 years and older is expected to double in size.(13) Also, a rapid increase of Dutch patients 
older than 75 years requiring dialysis is foreseen.(14) Next to a higher prevalence of end-stage 
renal disease (ESRD), these elderly people have important comorbidities, such as diabetes 
mellitus, cardiomyopathy, and peripheral vascular diseases.(15) The presence of these comor-
bidities and therefore an expected poor vessel quality challenge the creation of a reliable 
vascular access, which is a critical requirement for providing adequate HD.
Guidelines for vascular access do not include special recommendations for the elderly pa-
tients. Randomized controlled trials comparing dialysis access outcome in the elderly patient 
are lacking. The rationale for the DOQI to recommend RCAVFs before BCAVFs are lower 
morbidity rates associated with their creation, greater durability compared with other access 
types, and conservation of proximal access sites for future use.(4) An increased risk of RCAVF 
failure in the elderly patient and benefi t of BCAVFs was reported in a meta-analysis.(4) How-
ever, studies reporting on outcome of RCAVFs and BCAVFs in the elderly patients are diffi  cult 
to interpret due to diff erent patient populations, diff erent cutoff  points for age groups, and 
diff erent outcome measures regarding patency. However, our study in elderly patients shows 
signifi cant higher primary, primary-assisted and secondary patency (at 1 and 2 years) rates 
in elderly patients with BCAVFs compared to patients with RCAVFs. This means that patients 
who received BCAVFs had a larger intervention-free and thrombosis-free access survival and 
time to access abandonment was longer. This lower reintervention rate is essential for this 
specifi c population of elderly HD patients in which, according to other studies, poor survival 
was measured.(3,16) We believe that in a group of patients with a short life expectancy, preser-
vation of future access sites is less important. Because of this, we propose BCAVFs to be fi rst 
choice fi stula in the elderly patient.
Next to patency rates, another key outcome measure in the elderly is the QoL, which is increas-
ingly being evaluated for other vascular interventions.(17) The QoL is defi ned by the WHO as 
Table 3. Quality of life (QoL) analyses after fi stula placement compared to QoL after autologous bypass 
surgery26
Domain
Fistula
(N=30)
Autologous bypass
(N=33)
Physical health 59 60.7
Psychological health 70 67.3
Social relationships 79 63.1
Environmental 75.5 68.9
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an individual’s assessment of physical, psychological and social well-being that incorporates 
a patient’s individual perception of its disease and functioning.(10) Psychometric properties 
of the WHOQOL-BREF are good with studies that have shown good internal consistency, 
validity, and good sensitivity to change.(18,19) In our study, a relative high overall global QoL 
score was measured. Due to the poor survival in the studied population, the QoL analysis 
could only be performed in a relative small amount of the patents that made it impossible 
to compare QoL between the BCAVF group and RCAVF group. Despite these small numbers, 
we think it is important to describe the QoL in this population. The fact is that most patients 
in which QoL was measured belonged to the RCAVF group. The RCAVF group had the worst 
patency and most re-interventions, so QoL was measured in the group of patients with the 
worst outcome. Our high QoL scores are consistent with the literature on this subject. Elderly 
dialysis patients have been found to be more accommodating to their disease and dialysis.
(20,21) Besides this, QoL of the elderly dialysis patient did not differ greatly when compared 
to the QoL of an elderly person from the general population and patients after peripheral 
bypass surgery, as we also demonstrated.(12,22) So these elderly dialysis patients, in which 
survival was poor, seems to maintain a relative high QoL despite the discomforts of dialysis. 
It remains important to incorporate QoL in dialysis care, since perceived mental health seems 
to be a predictor of morbidity and mortality in patients with ESRD and therefore a measure of 
the quality of dialysis care.(23) This could be done by incorporating QoL questionnaires in the 
admission protocol for access surgery.
CONCLUSION
The BCAVFs should be considered before RCAVFs in HD access in elderly patients because of 
a longer intervention-free and thrombosis-free interval time. The QoL was surprisingly high 
in this population despite a high mortality rate.
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ABSTRACT
Background: Critical limb ischemia (CLI) has a poor outcome when left untreated. The benefits 
of revascularization in the very elderly might be limited because of co-morbidities and short 
life expectancy. Therefore, optimal management of CLI in the elderly is not straightforward. 
We analysed treatment results for elderly patients with CLI (Rutherford 4 or 5/6) in our clinic.
Methods: Hospital charts of all patients >70 years of age diagnosed with Rutherford stage 4-6 
peripheral arterial disease between January 2006 and December 2009 were reviewed. We 
divided patients into two age groups (70-79 and ≥80 years) to compare treatment results. 
Primary interventions were defined as conservative, endovascular, reconstructive surgery, 
and amputation. Outcome measures were mortality, reintervention, and major amputation 
rates.
Results: There were 191 patients (99 (52%) were women), median age was 78,4 years, range 
70-98 years. Altogether, 119 (62%) patients were aged 70-79 years, and 72 (38%) were ≥80 
years. The primary intervention was equally divided over the two age groups (p=0,21). 
Trans-Atlantic Inter-Society Consensus on Management of Peripheral Arterial Disease (TASC 
II) classifications of aortoiliac lesions were not significantly different regarding intervention 
(p=0,62) or age (p=0,39). TASC II classification of femoropopliteal lesions was significantly 
different relative to intervention (p<0,01) but not different between age groups (p=0,68). 
Mortality rate after reconstructive surgery was significantly higher in the oldest age group 
(p<0,01). After conservative treatment, endovascular treatment or amputation, the mortal-
ity rates were not significantly different between the two age groups (respectively p=0,06; 
p=0.33 and p=0,76). Reintervention rate was 51 % in the 70- to 79-year group compared to 
32% in the ≥80 year group. After initial treatment, major amputations were performed in 10% 
in the 70- to 79-year group compared to 13% in the ≥80 year group.
Conclusion: In patients aged  ≥80 years, surgical revascularization resulted in a significant 
higher mortality rate in our clinic, whereas primary conservative, endovascular treatment 
and amputation resulted in similar mortality in both age groups. When considering surgical 
revascularization in the very elderly, surgeons should focus on careful patient selection.
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INTRODUCTION
Critical limb ischemia (CLI) is the most advanced form of peripheral artery disease (PAD), 
presenting as ischemic rest pain, ulcers, or gangrene. It results from chronic, progressive, 
multilevel atherosclerotic lesions. (1) This severe type of vascular disease is associated with 
high morbidity and mortality rates and with diminished quality of life. (2,3) As the general 
population is growing older, an increasing number of very elderly patients suff er from CLI 
(2) The high prevalence of serious medical co-morbidities in this population aff ects outcome 
of treatment. Consequently, management of these patients can be diffi  cult. (2) When left 
untreated, CLI is associated with a poor outcome. (4) Treatment options are bypass surgery 
and endovascular revascularization, such as balloon angioplasty with or without stent 
placement. In the absence of an outfl ow vessel or in the presence of severe co-morbidities 
that prohibit major surgery, amputation is a treatment option. Finally, some patients in the 
former category with limited tissue loss and good response to painkillers can be managed 
conservatively without amputation.
It is known that CLI patients who undergo successful revascularization survive longer and 
have an increased quality of life compared to patients who are treated conservatively or 
by primary amputation. (2) Not all revascularizations are successful however, and in elderly 
patients its benefi ts are curtailed by an increased (cardiovascular) morbidity and mortality. 
Furthermore, the very elderly have a shorter life expectancy. Therefore, the advantage of 
revascularization in elderly patients with CLI may be limited. There is confl icting evidence on 
the success of lower extremity bypass surgery and angioplasty in the elderly. (1-3) The BASIL 
trial is the only randomized trial on bypass versus angioplasty in critical limb ischemia. (5) The 
investigators concluded that patients with a life expectancy of more than 2 years perform 
better with surgical revascularization in terms of amputation free survival (AFS).
However, none of these papers described the outcome of all four management strate-
gies, including amputation and conservative management. This study compared all four 
treatment options in elderly patients with CLI. Outcome was reported as 30-day, and 1- and 
2-year mortality rates , reinterventions, and major amputations. The aim of our study was to 
evaluate treatment in our population of elderly patients suff ering from CLI and analyse the 
rates of mortality and reinterventions after the initial treatment.
MATERIALS AND METHODS
Trial design
We performed a search of all patients with CLI treated in our hospital between January 2006 
and December 2009. CLI was defi ned as stage 4-6 according the Rutherford classifi cation. 
Data from patient records were collected in a database that contained the following items: 
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age, sex, date of first visit, level of PAD, TASC II classification (6), primary intervention, number 
and type of reinterventions, death, complications, co-morbidities (diabetes, smoking, hyper-
tension, impaired renal function, heart failure). Primary interventions were classified as con-
servative, endovascular revascularization, surgical revascularization and major amputation. 
Reinterventions were endovascular revascularization, surgical revascularization, and minor 
and major amputation. The TASC II classification was determined based on angiography and/
or Magnetic Resonance Angiography (MRA). We created two age groups: 70-79 years and ≥80 
years. Outcome was measured in terms of mortality, major amputations and all reinterven-
tions after four possible initial treatments. We calculated mortality at 30 days, and 1 and 
2 years after the first intervention. All reinterventions and major amputations as a second 
intervention were specified per age group and first treatment group. Amputations were clas-
sified as minor (toe or forefoot) or major (above the ankle). If patients underwent only a minor 
amputation without revascularization, not followed by a major amputation within 1 week, 
we considered the treatment conservative. If a minor amputation was followed by a major 
amputation within 1 week, we considered the first intervention to be major amputation. 
Follow-up data were obtained from hospital records by K.L. and M.Z. If the date of death was 
not reported, one of the authors (K.L.) contacted the general practitioner to confirm the date.
Vascular workup and and treatment strategy
A vascular surgeon initially evaluated the patients, and an ankle-brachial index was deter-
mined. In addition, duplex scanning and/or MRA were used to evaluate treatment options. All 
patients received statins. Patients who were treated with an autologous peripheral bypass re-
ceived oral anticoagulant (acenocoumarol), the other patients were given acetylsalicylic acid. 
A dedicated multidisciplinary vascular board comprising vascular surgeons and radiologists 
conducted a weekly review of the patiens. Before surgical revascularization, a cardiologist 
evaluated the patients to estimate the operative risk and optimize cardiac status if possible. 
Treatment policy was decided at the weekly board meeting based on technical possibilities 
and the patient’s general health and severity of ischemia according the Rutherford index. 
In general the following strategies were initiated. Conservative management was started in 
patients with poor general health who had acceptable benefit from pain reduction therapy 
on rest pain or minor tissue loss (Rutherford 4-5). Endovascular treatment was the first choice 
whenever technically possible, depending on the morphology of arterial stenoses or occlu-
sions in the affected limb. Surgical revascularization was planned for lesions not suitable 
for endovascular approach in patients with acceptable perioperative risk as estimated by 
a cardiologist, anaesthetist, and vascular surgeon. Three patients in the population 70-79 
years of age underwent a suprainguinal bypass, as did two patients in ≥80 years group. All 
the other bypasses were infrainguinal. Primary amputation was performed in patients with 
severe ischemia (Rutherford 6) and general health deemed unfit for vascular reconstruction 
surgery or in the absence of a target outflow vessel.
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Statistical analysis
SPSS 19.0 for Windows package (SPSS Inc., Chicago, IL, USA) was used for the statistical analy-
sis. Frequencies and descriptive statistics were used for reporting the baseline characteristics 
of the patient group. The chi-square test was used to determine statistical signifi cance.
Survival interval rates were calculated with Kaplan-Meijer curves and the log-rank test 
was used to determine statistical signifi cance. A value of p < 0.05 was considered to denote 
statistical signifi cance.
RESULTS
This study included 191 patients, 99 (52%) of whom were women. The median age was 
78,4 years (range 70-98 years). Risk factors for developing PAD and co-morbidity in this 
population were distributed as follows: smoking (34%), hypertension (62%), diabetes (50%), 
haemodialysis (9%), heart failure (57%). We divided the population in two age groups. There 
were 119 (62%) patients aged 70-79 years and 72 (38%) patients aged ≥80 years. The ≥80 
years group contained signifi cantly more women (p<0,01). Disease severity was classifi ed 
as Rutherford 4 in 100 (52%) patients and as Rutherford 5/6 in 91 (48%) patients. We noted 
a trend towards Rutherford 5/6 in patients aged ≥80 years (p=0,09). The younger group con-
tained more smokers (p<0,05), other risk factors and co-morbidities were not signifi cantly 
diff erent (Table 1).
Table 1. Demographic characteristics in diff erent age groups with chronic critical limb ischemia
Characteristic 70-79
(N=119)
80+
(N=72)
P value*
Age, y, mean ± SD 74,5 ± 2.8 85,0 ± 4,2
Gender (%) <0.01
 males 71 (60%) 21 (29%)  
 females 48 (40%) 51 (71%)  
Risk factors and comorbidity (%)
 Smoking 48 (40%) 17 (24%) <0.05 
 Diabetes 64 (54%) 32 (44%) 0.21 
 Hypertension 78 (66%) 40 (56%) 0.17 
 Hemodialysis 10 (8%) 8 (11%) 0.35 
 Heart failure 67 (56%) 42 (58%) 0.78 
Rutherford classifi cation 0.09
 Class 4 68 (57%) 32 (44%) 
 Class 5/6 51 (43%) 40 (56%) 
*Calculated by chi-square test
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Patients were stratified according to the primary treatment strategy: conservative treatment 
in 20 (10%) patients; endovascular procedure in 89 (47%); surgical revascularization in 61 
(32%); major amputation in 21 (11%). Types of primary intervention were equally divided in 
the two age groups (p=0,21) (Table 2).
We found data to determine severity of PAD according the TASC II classification in 173 pa-
tients, but no data were found for the other 19 patients. The TASC II classification of aortoiliac 
lesions showed no significant difference in relation to intervention (p=0,62) or age (p=0,39). 
TASC II classification of femoropopliteal lesions showed a significant difference in relation 
to intervention (p<0,01) Patients initially treated with reconstructive surgery and amputa-
tion had more severe lesions than patients treated conservatively and with an endovascular 
procedure. No significant difference was seen in relation to age (p=0,68). With regard to the 
number of outflow arteries, there was no significant difference in relation to intervention or 
age (p=0,06 and p=0,09, respectively) (Table 3).
Survival was measured at 30 days and 1 and 2 years after the first intervention. Among 
the patients treated conservatively, endovascularly, or with major amputation, there were 
no significant differences in survival between the two age groups. However, in the group 
treated conservatively there is a trend toward higher mortality rates in the oldest popula-
tion. Among the patients who underwent reconstructive surgery as the primary treatment, 
patients aged ≥80 years had a significantly higher mortality rate than the younger patients 
(p<0,01) (Table 4).
Reintervention and major amputation following the initial treatment strategy were distrib-
uted as follows. After conservative treatment, two patients underwent a second intervention 
(each had a minor amputation but no major amputation). After initial endovascular treat-
ment, 52% of patients underwent reintervention, with 10% having a major amputation. In 
the surgically treated group, 51% needed a second intervention and 11% a major amputa-
tion. After a major amputation five patients (24%) were amputated at a higher level (Figure 1 
and Table 5).
Table 2. Types of first intervention according to different age groups
Intervention 70-79
(N=119)
80+
(N=72)
Conservative 9 (8%) 11 (15%)
Endovascular 55 (46%) 34 (47%) 
Reconstructive Surgery 43 (36%) 18 (25%) 
Major Amputation 12 (10%) 9 (13%) 
*Calculated by chi-square test ‘chi-square = 4.593a df (3); p = 0.21’
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DISCUSSION
Our most important fi nding was the fact that surgical revascularization is a very high risk 
procedure in patients aged ≥80 years with CLI in our clinic. In our population, the 22% 30-
day mortality was high compared to no mortality after endovascular treatment and primary 
amputation. In the longer term, these diff erences in mortality between the diff erent manage-
ment strategies were even more pronounced in the group ≥80 years. Arvela et al. described 
high operative risk of patients aged ≥80 years with CLI and a short life expectancy in a earlier 
study. (7) Currently, there are no specifi c guidelines for the treatment of elderly patients with 
chronic CLI, and decision-making is a challenge for the vascular surgeon. Untreated chronic 
Table 3. TASC-classifi cation of aortic-iliacal lesions and femoral popliteal lesions and number of outfl ow 
arteries according type of intervention
Intervention
Conservative Endovascular Reconstructive
Surgery
Amputation
70-79
(N=7)
80+
(N=8)
70-79
(N=55)
80+
(N=33)
70-79
(N=43)
80+
(N=15)
70-79
(N=6)
80+
(N=6)
TASC aorto-iliac
 TASC*Intervention: p=0.62# 
 TASC*Age groups: p=0.39# 
 none 7 (100%) 8 (100%) 36 (65%) 27 (82%) 31 (72%) 11 (73%) 5 (83%) 6 (100%) 
 Type A - - 9 (16%) 4 (12%) 5 (12%) 2 (13%) 1 (17%) - 
 Type B - - 6 (11%) 2 (6%) 4 (9%) - - - 
 Type C - - 3 (5%) - 2 (5%) 1 (7%) - - 
 Type D - - 1 (2%) - 1 (2%) 1 (7%) - - 
TASC femero-popliteal
 TASC*Intervention: p<0.01# 
 TASC*Age groups: p=0.68# 
 none - 1 (13%) 3 (5%) - - - - - 
 Type A 2 (29%) 1 (13%) 9 (16%) 8 (24%) 5 (12%) 2 (13%) - - 
 Type B 4 (57%) 2 (25%) 36 (65%) 19 (58%) 24 (56%) 7 (47%) 2 (33%) 3 (50%) 
 Type C - 3 (37%) 4 (7%) 4 (12%) 13 (30%) 6 (40%) 1 (17%) 2 (33%) 
 Type D 1 (14%) 1 (13%) 3 (5%) 2 (6%) 1 (2%) - 3 (50%) 1 (17%) 
Outfl ow arteries
 Outfl ow*Intervention:p=0.06# 
 Outfl ow*Age groups: p=0.09# 
 none 1 (14%) 2 (25%) 2 (4%) 3 (9%) 1 (2%) 1 (7%) 2 (33%) 1 (17%) 
 1-vessel 3 (43%) 3 (37%) 16 (29%) 15 (45%) 18 (42%) 8 (53%) 4 (67%) 2 (33%) 
 2-vessel 1 (14%) 3 (37%) 16 (29%) 10 (30%) 16 (37%) 3 (20%) - 3 (50%) 
 3-vessel 2 (29%) - 21 (38%) 5 (15%) 8 (19%) 3 (20%) - - 
#Calculated by chi-square test
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Table 4. Mortality rates at 30-days, 1-year and 2-years after first intervention according to different age 
groups
Intervention groups 70-79
(N=119)
80+
(N=72)
P-value*
Total
 30-day mortality rate 8/119 (7%) 5/72 (7%)  
 1-year mortality rate 20/119 (17%) 24/72 (33%)  
 2-year mortality rate 29/119 (24%) 32/72 (44%)  
Conservative 0.06
 30-day mortality rate 0/9 (0%) 1/11 (9%) 
 1-year mortality rate 0/9 (0%) 6/11 (55%) 
 2-year mortality rate 2/9 (22%) 7/11 (64%) 
Endovascular 0.33
 30-day mortality rate 4/55 (7%) 0/34 (0%) 
 1-year mortality rate 8/55 (15%) 8/34 (24%) 
 2-year mortality rate 12/55 (22%) 9/34 (26%) 
Reconstructive <0.01
 30-day mortality rate 3/43 (7%) 4/18 (22%) 
 1-year mortality rate 8/43 (19%) 9/18 (50%) 
 2-year mortality rate 10/43 (23%) 12/18 (67%) 
Amputation 0.76
 30-day mortality rate 1/12 (8%) 0/9 (0%) 
 1-year mortality rate 4/12 (33%) 1/9 (11%) 
 2-year mortality rate 5/12 (42%) 4/9 (44%) 
*Calculated by log rank test
Table 5. Re-intervention and major amputation rates after first intervention according to different age groups
Patient outcome
(N=191)
70-79
(N=119)
80+
(N=72)
Total
(N=191)
All re-interventions (%) 61 (51%) 23 (32%) 84 (44%)
 Conservative 2/9 (22%) 0/11 (0%) 2/20 (10%) 
 Endovascular 30/55 (55%) 16/34 (47%) 46/89 (52%) 
 Reconstructive Surgery 25/43 (58%) 6/18 (33%) 31/61 (51%) 
 Amputation 4/12 (33%) 1/9 (11%) 5/21 (24%) 
Major amputations (%) 12 (10%) 9 (13%) 21 (11%)
 Conservative 0/9 (0%) 0/11 (0%) 0/20 (0%) 
 Endovascular 4/55 (7%) 5/34 (15%) 9/89 (10%) 
 Reconstructive Surgery 4/43 (9%) 3/18 (17%) 7/61 (11%) 
 Major amputation 4/12 (33%) 1/9 (11%) 5/21 (24%) 
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CLI is associated with a dismal prognosis. (8) Multiple studies have shown that successful 
surgical revascularization in CLI patients has a positive eff ect on survival and quality of life 
when compared to conservative treatment or primary amputation. (8-10) Our results showed 
a similar trend in the younger age group. The surgical and endovascular groups had a better 
survival. Advanced age is considered a relative contraindication for surgical revascularization 
in patients with PAD. (1) In contrast, some institutions have described excellent results of CLI 
treatment in the elderly. In a retrospective study, Pomposelli reported good short- and long-
term outcomes after 292 bypass operations as limb salvage for patients  ≥80 years. (2) The 
5-year survival rate was 44% with a limb salvage rate of 92%. Brosi et al reported a 30-day 
mortality of 6% after endovascular treatment, 20% after surgical revascularization, and 17,9% 
after conservative treatment in octogenarians in a prospective cohort study. (1) They con-
cluded that revascularization in octogenarians is worthwhile but comes at a cost of a higher 
periprocedural mortality. However, the did not report the follow-up of patients treated with 
primary amputation. The result of our study in the ≥80 years group are comparable to those 
of Brosi et al. with a 30-day mortality of zero after endovascular treatment, 22% after surgical 
revascularization, and 9% after conservative management. In our population primary ampu-
tation did not lead to any deaths in nine patients after 30 days. This was probably due to the 
small numbers.
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Figure 1. Flowchart of fi rst intervention and re-interventions according to age groups.
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In the literature, reconstructive vascular surgery of the lower limb is associated with high 
perioperative cardiovascular risk, with mortality rates range from 2% to 6%. (2-4) We found 
similar 30-day mortality rate of 7% in patients aged 70 to 79 years, but in the ≥80 years group 
we found a 30-day mortality rate of 22%. Also, the overall mortality rate after reconstructive 
surgery was significant higher in patients aged ≥80 years. This raises the question at what 
cost limb salvage should be attempted in this high risk group. Alternative treatments, such 
as amputation or conservative treatment, could at least be considered with these mortality 
figures. However, we should bear in mind that a major amputation has a significant impact 
on the quality of life (QoL) and on survival. (11-13) On the other hand, revascularization does 
not prevent amputation in all cases. In our study, 51% of patients treated with surgical revas-
cularization required reintervention, and this reintervention was a major amputation in 24%. 
Whether this influences the quality of life in these patients was not measured in this study, 
but it can be assumed that this has a negative effect.
Other studies have also shown that in very elderly patients the benefit of surgical revascu-
larization is limited because of an increased risk of cardiovascular events. (14-16)
Two large clinical trials described long-term survival of patients with CLI after revascular-
ization: 85 % 1-year survival in the PREVENT III trial and 70% 2-year survival in the BASIL trial. 
(5,17) We showed a 1-year survival of 82% after endovascular treatment and 70% after surgical 
revascularization, which is comparable to the results of the BASIL trial. (5) In the ≥80 years 
group, however, vascular surgery was associated with 50% mortality at 1 year, again raising 
the question whether surgery is feasible in this group. Lepäntalo and Matzke described a 
cohort of patients with CLI where no reconstruction was performed. (4) At 1 year, 54% of the 
legs were saved, and survival was 46%. This is considered a poor outcome, but it might be the 
best option in very high risk patients with controllable pain and limited tissue loss.
We are aware that the definition of CLI is important in this matter. CLI with limited tissue loss 
or pain can be managed conservatively in the non-ambulant elderly, whereas severe tissue 
loss in patients with a vascular lesion unsuitable for endovascular treatment represents the 
other end of the spectrum. In all age categories, the patient groups treated with endovascular 
intervention had lower mortality compared to the other treatment groups. These differences 
can of course be partly explained by the selection of patients by the vascular surgeon. This 
selection is illustrated by the significantly less extensive disease according to the TASC II 
classification in patients treated by endovascular means. The surgical revascularization and 
primary amputation groups represent a category with severe CLI unsuitable for conservative 
or endovascular treatment, because we use the ‘endovascular first’ strategy, especially in the 
very old. Therefore, we believe that it is possible to compare the amputation and surgical 
groups in terms of mortality.
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We believe that patient selection could be the key to improving results of CLI treatment in the 
elderly population. Even though cardiovascular assessment by a cardiologist before surgical 
reconstruction is standard procedure in our clinic, it could not prevent a high mortality among 
very old patients. For the benefi t of the patient and in light of the curtailment of healthcare 
costs, it would be worthwhile to prevent futile eff orts in limb salvage. Risk prediction has 
been described by Schanzer et al. (18) Their group was able to identify patients with a more 
than 50% risk of death or amputation at 1 year. In future eff orts for limb salvage in the very 
elderly, risk prediction could improve results. A risk score was not used in our clinic during the 
study period but will be calculated in a recently started prospective study in our department.
Although TASC II classifi cations were similar in the two age groups, the number of outfl ow 
vessels was signifi cantly less in the group ≥80 years. This was not refl ected in a diff erent pri-
mary treatment strategy (Table 5) but could account for worse outcome in the elderly group. 
On the other hand, we found no signifi cant diff erences in co-morbidity or disease severity 
according to the Rutherford classifi cation in the two age groups. As mentioned above, the 
four types of primary intervention were similarly distributed in both age groups, suggesting 
that patient’s age did not aff ect the treatment choice of the surgeon. In our opinion, the 
study design gives a realistic view of everyday vascular surgical practice and evaluates the 
performance of our clinic regarding the treatment of CLI. (19) This has encouraged us to start a 
prospective observational study for treatment of CLI in the elderly.
We are aware that treatment decisions in CLI should be individualized and based on life 
expectancy, functional status, anatomy of the arterial occlusive disease and surgical risk. (13,20) 
A better estimation of the surgical risk would be helpful. However, determining what surgical 
risk is acceptable when facing a major amputation is even more diffi  cult. This is an important 
issue on an individual level and on socioeconomic level. Future studies should measure QoL 
and attempt better risk prediction to improve outcomes of treatment of CLI.
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ABSTRACT
Introduction: Optimal management of an abdominal aortic aneurysm (AAA) in the elderly is 
not straightforward. We evaluated treatment results of elderly patients with asymptomatic 
abdominal aortic aneurysm that met the treatment criteria in our clinic.
Methods: Hospital charts between January 2005 - December 2012 were reviewed of all pa-
tients 70 years and older diagnosed with AAA with a diameter that met the treatment criteria. 
Patients were stratified by age (group I: 70-79 years, group II: 80 years or older) and treatment. 
Outcome was measured in terms of survival and complications.
Results: In total 283 patients (240 (85%) men, median age 77,4 years) were included, 211 (75%) 
in group I and 72 (25%) in group II. There was an overall significantly higher mortality rate in 
the octogenarians (p<0.01). This difference was not seen in the groups treated conservatively 
and with OPEN repair. However, in the EVAR group there was a significantly higher mortality 
rate in octogenarians (p<0.01).
Conclusion: Long-term outcome after EVAR procedures results in higher mortality rates for 
the population older than 80 years as compared to the group aged 70-79 years.
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INTRODUCTION
Abdominal aortic aneurysm (AAA) is a common vascular disease and can lead to serious life-
threatening complications if left untreated in patients with a diameter over 55 mm. AAA is 
diagnosed in 5-10 % of men aged 65 years or older. [1] Approximately 75% of AAAs are asymp-
tomatic and are found coincidentally during physical examination or by ultrasonography or 
CT scanning. [2]
Optimal management of an AAA is not straightforward. Treatment of AAA should be based 
on patient’s comorbidity and aorta morphology. An important issue in decision-making is the 
size-related risk of aneurysm rupture in relation to the mortality risk of a surgical intervention. [2]
Open abdominal repair (OPEN) was for many years the gold standard for treatment of AAA. 
[3] However, endovascular aortic repair (EVAR) is a safe and eff ective alternative treatment op-
tion, which made it possible to treat a larger proportion of the population suff ering from AAA. 
[4] The EVAR-1 trial revealed similar overall mortality rates in patients after undergoing EVAR 
and/or OPEN repair of an AAA. However, the long-term complications and reinterventions 
after EVAR were more common among older patients. [5] In case of signifi cant comorbidity 
can be chosen for a conservative treatment. Given the increased risk of rupture this should 
be done in good consultation with the patient.
Despite the Society of Vascular Surgery / North American Chapter of the International Soci-
ety for Cardiovascular surgery (SVS/ISCVS) [6] - and the European Society for Vascular Surgery 
(ESVS) [7] reporting standards, treatment of AAA should be based on the individual patient. 
Especially in elderly patients with considerable comorbidity it remains diffi  cult and challeng-
ing to choose the best option of treatment. For this reason we evaluated treatment results 
of elderly patients with abdominal aortic aneurysm that met the treatment criteria in our 
clinic. The aim of this study was to determine the optimal treatment of asymptomatic AAA in 
elderly patients. In addition, we conducted a systematic review of the literature concerning 
treatment of AAA in elderly patients.
PATIENTS AND METHODS
I. Analysis of registered data
Patients’ characteristics
A retrospective observational clinical review was conducted from data of 283 consecutive 
AAA patients treated between January 2005 and December 2012 at the vascular surgery de-
partment of the Amphia Hospital. Patients were stratifi ed by age: patients between 70 - and 
79 years (group I) and patients 80 years or older (group II). Data of the patient characteristics 
are listed in Table 1. The study conforms the STROBE guidelines
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Risk factors and comorbidity
Risk factors and comorbidity were registered prospectively of all patients during their visit to 
the outpatient clinic. The risk factor and comorbidity management, according to the Trans-
Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease 
(TASC) [8] and the American Heart Association/American College of Cardiology (AHA/ACC) [9] 
were either conducted by a vascular specialist or cardiologist preoperatively in the outpa-
tient clinic or during admission before operation. The American Society of Anesthesiologists 
(ASA) classification [10] of patients was determined according to their general preoperative 
condition prospectively. Data of the risk factors and comorbidity are listed in Table 1.
Table 1. Patient and AAA-characteristics of all patients aged 70 years or older treated for AAA during the 
study period
Characteristics Group I
(n=211)
Group II
(n=72)
P-value*
GENDER 0,46 
 Male 177 (84) 63 (88) 
 Female 34 (16) 9 (12) 
AGE (years, mean±SD) 75,3±3,0 83,5±2,7 
RISK FACTORS 
 Smoking 71 (34) 5 (7) <0,01 
 Diabetes 27 (13) 7 (10) 0,49 
 Hypertension 94 (45) 22 (31) <0,05 
 COPD 40 (19) 21 (29) 0,30 
 Heart failure 84 (40) 42 (58) <0,01 
MEDICATIONS 
 Statins 143 (68) 41 (57) 0,10 
 Acetylsalicylic acid 154 (73) 49 (68) 0,42 
 Acenocoumarol 23 (11) 10 (14) 0,50 
ASA-CLASSIFICATION 0.26 
 Classification 2 80 (38) 19 (26) 
 Classification 3 122 (58) 49 (68) 
 Classification 4 9 (4) 4 (6) 
DIAMETER AAA 
 Aneurysm (mean;min;max) mm 62;40;110 64;50;95 0,16
Data are presented as n and (%), unless otherwise specified.
AAA=Abdominal aorta aneurysm; ASA=American Society of Anesthesiologists; Group I= patients between 70-79 
years; Group II=patients 80 years or older.
*Calculated by Chi-square test
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AAA characteristics
Indications for aneurysm repair were an aneurysm diameter ≥ 5.0 (female) or ≥ 5.5 (male) 
or growth of the aneurysm >0.5 cm within 6 months. Exclusion criteria comprised patients 
who needed branched or fenestrated stent grafts, patients with juxtarenal, - suprarenal, - or 
thoraco - abdominal aneurysms or patients presenting with a symptomatic - or ruptured 
AAA. The surveillance (with a Siemens Defi nition CT-scan) protocol was CTA at 1 - and 12 
months after EVAR, and if no complications were detected, a CT (without contrast) in associa-
tion with plain abdominal X-ray annually thereafter. Data of the AAA characteristics are listed 
in Table 1.
Treatment
Figure 1. is a fl ow chart of the diff erent treatment options and their general criteria. In this 
study patients with symptomatic and ruptured AAA were excluded.
Conservative. Conservative management was started in patients where the operation risk 
was estimated greater than the mortality risk due to rupture of the aneurysm. This group 
contains mostly patients with advanced age, poor general health and an aneurysm that 
was not suitable for endovascular treatment.
OPEN. For all OPEN procedures the Dacron aorta graft was used.
EVAR. Three diff erent stent graft systems were used for endovascular treatment of the AAA 
during the study period: Cook® Zenith Flex® AAA Endovascular Graft [11], Gore® Excluder® 
AAA Endoprosthesis [12] and the Medtronic® Endurant® AAA Stent Graft System [13].
 
 
 
 
 
 
	  
	  
Conservative	  	  
	  
EVAR	  
	  
OPEN	  
-­‐	  AAA	  size:	  
	  	  	  	  >	  50mm	  in	  women	  
	  	  	  	  >	  55mm	  in	  men	  
-­‐	  infrarenal	  
-­‐	  suitable	  morphology	  
-­‐	  symptomatic	  
-­‐	  ruptured	  
-­‐	  AAA	  size:	  	  
	  	  	  	  <	  50mm	  in	  women	  
	  	  	  	  <	  55mm	  in	  men	  
-­‐	  asymptomatic	  
-­‐	  high-­‐risk	  patients,	  
unfit	  for	  surgery	  
-­‐	  desire	  of	  patient	  
-­‐	  AAA	  size:	  
	  	  	  	  >	  50mm	  in	  women	  
	  	  	  	  >	  55mm	  in	  men	  
-­‐	  symptomatic	  
-­‐	  ruptured	  
Figure 1. fl ow chart of treatment options.
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The EVAR - and OPEN procedure were performed according to standard vascular - and 
endovascular techniques. All EVAR - and OPEN procedures were performed by a vascular sur-
geon. The requirements for these standard available stent grafts were driven by the Society 
of Vascular Surgery / North American Chapter of the International Society for Cardiovascular 
surgery (SVS/ISCVS) [6] - and the European Society for Vascular Surgery (ESVS) [7] reporting 
standards. Data of the EVAR procedures are listed in Table 2.
Complications
In the Netherlands, the Association of Surgeons of the Netherlands (ASN) has agreed on one 
common definition of complications. [14-16] The definition of a complication is: ‘‘an unintended 
and unwanted event or state occurring during or following medical care, that is so harmful 
to a patient’s health that (adjustment of ) treatment is required or that permanent damage 
results. The complication may be noted during hospitalization, until 30 days after discharge 
or transfer to another department.
The definition of endoleaks, the decision to intervene and the type of reintervention, endo-
vascular (stent graft, percutaneous embolization) - or surgical reintervention (ligation), were 
driven by the SVS/ISCVS - and ESVS reporting standards. [6,7] Endoleak type 1 was defined as 
a graft that does not seal completely at the extremities, endoleak type 2 as backfilling of the 
aneurysm from other smaal vessels in the aneurysm wall. Data of the endoleaks are listed in 
Table 2.
Table 2. Summary of EVAR procedures (n=120), endoleak (n=18) and reinterventions (n=8).
Revascularization Group I
(n=85)
Group II
(n=35)
P-value*
EVAR 0,72 
 Medtronic® Endurant® AAA Stent Graft System 57 (67) 26 (74) 
 Cook® Zenith Flex® AAA Endovascular Graft 24 (28) 8 (23) 
 Gore® Excluder® AAA Endoprosthesis 4 (5) 1 (3) 
Endoleak † 0,65 
 Type 1 2 (2) 0 (0) 
 Type 2 11 (13) 5 (14) 
REINTERVENTION 8 - 
 Embolectomy 4 - 
 Postoperative bleeding 2 - 
 Stentgraft/extension 1 - 
 Urokinase 1 - 
Data are presented as n and (%), unless otherwise specified.
AAA=Abdominal aorta aneurysm; EVAR=Endovascular aneurysm repair; Group I= patients between 70-79 years; 
Group II=patients 80 years or older.
†: defined according to the 2011 guidelines of the European Society for Vascular Surgery (ESVS)15
*Calculated by Chi-square test
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II. Review of the literature
A systematic search of literature was performed in the medical database PubMed. In addi-
tion, we manually searched the reference lists of relevant articles to identify articles missed 
by electronic searches. Language was restricted to English, German and Dutch. We did not 
systematically search abstract books of conference proceedings, did not hand search-leading 
journals, and did not contact leading authors in the fi eld to retrieve potential extra papers.
Types of studies
Any prospective or retrospective study evaluating the treatment of AAA in elderly patients 
was considered. The studies had to be published from January 2003 till December 2012. They 
had to describe an original patient series of elderly AAA patients. Studies had to describe a 
consecutive patient series to be eligible for inclusion.
Study selection
Titles and/or abstracts of all selected manuscripts in the initial search were screened by two 
reviewers (KL and HF) independently to identify potentially relevant articles, using the inclu-
sion criteria. Discrepancies in judgment were resolved after discussion and, when necessary, 
after mediation of a third reviewer (LL). Full text of these articles was retrieved for further 
analysis.
Study quality and data extraction
Studies fulfi lling all inclusion criteria were checked on study quality characteristics by two 
reviewers (KL and HF) independently. Assessment of study quality was done using a form 
based on a checklist of the Cochrane Library. [17]
Registration and statistical analysis
SPSS 20.0 for Mac (SPSS Inc., Chicago, IL, USA) was used for the statistical analysis. Frequencies 
and descriptive statistics were used for reporting the baseline characteristics of the patient 
group. The chi-square test was used to determine statistical signifi cance. Survival interval 
rates were calculated with Kaplan Meijer curves and the log-rank test was used to determine 
statistical signifi cance. A p-value below 0.05 was considered to denote statistical signifi cance.
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RESULTS
I. Analysis of registered data
Patients’ characteristics, comorbidity and AAA characteristics
There were 283 AAA patients (group I: n=211, 75% vs. group II: n=72, 25%) included. This 
population consisted of 240 men (85%) and 43 women (15%). Median age was 77,4 years 
(range 70-91). The 30-day postoperative mortality rate was 1,4%. Risk factors and comor-
bidities were distributed as follows: hypertension (41%), diabetes (12%), heart failure (45%), 
COPD (22%), smoking (27%) and 14% had already stopped smoking. Group I contained 
significantly more smokers (p<0.01) and more patients with hypertension (p<0.05) or heart 
failure (p<0.01), while other risk factors and comorbidities were not significantly different. No 
significant differences were found in use of statins and anticoagulation medication. ASA clas-
sification was not significantly different between age groups (p=0.26; Table 1). However, ASA 
classification was significantly higher in the conservative treated total (p<0.01) and youngest 
(p<0.01) group and a similar trend was seen in the oldest group (p=0.06; Table 3). The mean 
diameter of the aneurysms was: mean 62 mm (range 50-110) in group I and 64 mm (range 
50-95) in group II (Table 1).
Table 3. ASA classification according to intervention.
groups ASA 2 ASA 3 ASA 4 P-value*
Group aged 70-79 P<0,01 
 Conservative 5 17 7 
 EVAR 36 47 2 
 Open repair 39 58 0 
Group aged 80+ P=0,06 
 Conservative 4 21 4 
 EVAR 12 23 0 
 Open repair 3 5 0 
Total P<0,01 
 Conservative 9 38 11 
 EVAR 48 70 2 
 Open repair 42 63 0 
Data are presented as n, unless otherwise specified.
ASA=American Society of Anesthesiologists; EVAR=Endovascular aneurysm repair
*Calculated by Chi-square test
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Treatment
Patients were stratifi ed according to their treatment strategy: conservative n=58 (21%); EVAR 
n=120 (42%) and OPEN n=105 (37%). In both age groups an equal percentage of patients 
were treated with EVAR. However, in group II signifi cantly more patients were treated conser-
vatively compared to the patients in group I (p<0.01; Table 4).
The EVAR stent graft systems were divided as follows: in the period 2005-2008 we used the 
Cook® Zenith Flex® AAA Endovascular Graft (n=32, 27%) or Gore® Excluder® AAA Endopros-
thesis (n=5, 4%) and since 2008 we used the Medtronic® Endurant® AAA Stent Graft System 
(n=83, 69%). The occurrence of reinterventions after EVAR (n=8, 7%) was: embolectomy (n=4, 
50%), postoperative bleeding (n=2, 25%), stentgraft/extension (n=1, 13%) and urokinase 
(n=1, 13%) as listed in Table 2.
Indications for reinterventions (n=15, 14%) after OPEN procedure were: postoperative 
bleeding (n=5, 33%), embolectomy (n=3, 20%), abdominal wound dehiscence (n=2, 13%), 
intestinal ischemia (n=2, 13%), suspicion of intestinal ischemia or postoperative bleeding, 
but not found during laparotomy (n=2, 13%) and lower limb amputation (n=1, 7%).
Complications
Endoleak. Endoleak type 1 or 2 were diagnosed in 18 patients: group I n=13 (15%) and group 
II n= 5 (14%). A reintervention for an endoleak was indicated in 2 patients from group I. There 
was no diff erence in occurrence and treatment of an endoleak after EVAR between both age 
groups (p=0.65; Table 2).
Systemic. Systemic complications occurred in 71 patients: OPEN n=48 (46%) and EVAR 
n=23 (19%) (Table 5).
Survival
As listed in Table 6, Figure 2-4 there was an overall signifi cantly higher mortality rate in the 
group aged 80 years or older (p<0.01). In the conservative and OPEN group there was no 
diff erence between both age groups. However, in the EVAR group there was a signifi cantly 
higher mortality rate in group II (p<0.01). In the conservatively managed group of patients 
Table 4. Type of interventions according age group
Intervention Group I
(n=211)
Group II
(n=72)
Conservative 29 (14) 29 (40) 
EVAR 85 (40) 35 (49) 
Open repair 97 (46) 8 (11) 
Data are presented as n and (%), unless otherwise specifi ed.
EVAR=Endovascular aneurysm repair; Group I= patients between 70-79 years; Group II=patients 80 years or older.
*Calculated by chi-square test ‘chi-square = 36,547a df (2); p < 0,01’
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aged 70- to 79 years (n=29), 17 patients were deceased at the end of the follow-up, 1 patient 
(6%) died after a ruptured AAA, 6 (35%) due to recurrent disease and the cause of death of 
the other 10 patients (59%) could not be retrieved. In the conservatively managed group of 
patients aged 80 years and older (n=29), 22 patients were deceased at the end of follow-up, 
6 patients (27%) died after a ruptured AAA, 2 (9%) due to recurrent disease and the cause of 
death of the other 14 patients (64%) could not be retrieved.
II. Systematic review of the literature
Study selection
The search identified 95 potentially eligible studies of which 83 were excluded based on title 
and abstract. From the remaining 12 studies full articles were collected and evaluated. Nine 
articles were according to our inclusion criteria and were included in the systematic review. 
Study flow and reasons for exclusion are presented in Figure 5.
Study descriptions
Characteristics and conclusions of the included and evaluated 9 articles [18-26] are outlined in 
Table 7 and 8. These articles represented 5110 elderly patients elective treated for AAA over 
a period of 10 years. Articles on surgery only for ruptured AAA were excluded. Only 3 studies 
(33%) were prospective and 6 studies (66%) were retrospective. These studies reported on 
Table 5. Summary of complications after EVAR and OPEN repair and reinterventions.
Revascularization OPEN
(n=48)
EVAR
(n=23)
SYSTEMIC COMPLICATIONS 
 Pneumonia 9 1 
 Postoperative ileus 7 1 
 Delirium 5 1 
 Renal dysfunction 5 1 
 Heart failure 4 1 
 Myocardial infarction 4 2 
 Atrial fibrillation 3 4 
 Bladder retention 2 4 
 Respiratory insufficiency 2 1 
 Urinary tract infection 1 1 
 Seroma - 2 
 Other 6 4
Data are presented as n, unless otherwise specified.
; EVAR=Endovascular aneurysm repair;
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elderly patients undergoing EVAR (n=4), both OPEN and EVAR (n=4) and conservative (n=1) 
AAA treatment.
Patients characteristics
As listed in Table 8, a total of 4623 men (90%) and 487 women (10%) were evaluated, with 
a mean age of 75,7 years (range 68 - 85). The mean diameter of the aortic aneurysm was 60 
mm.
Table 6. Mortality rates at 30-days, 1-, 2-, 3- and 5-years after inclusion according to diff erent age groups
Intervention groups Group I
(n=211)
Group II
(n=72)
P-value*
TOTAL <0,01 
 30-day mortality rate 2/211 (1) 2/72 (3)  
 1-year mortality rate 27/211 (13) 20/72 (28) 
 2-year mortality rate 38/211 (18) 26/72 (36) 
 3-year mortality rate 48/211 (23) 30/72 (42) 
 5-year mortality rate 58/211 (27) 36/72 (50) 
CONSERVATIVE 0,68 
 30-day mortality rate 1/29 (3) 2/29 (7) 
 1-year mortality rate 12/29 (41) 13/29 (45) 
 2-year mortality rate 15/29 (52) 16/29 (55) 
 3-year mortality rate 16/29 (55) 18/29 (62) 
 5-year mortality rate 17/29 (59) 21/29 (72) 
EVAR <0,01 
 30-day mortality rate 0/85 (0) 0/35 (0) 
 1-year mortality rate 6/85 (7) 6/35 (17) 
 2-year mortality rate 10/85 (12) 9/35 (26) 
 3-year mortality rate 13/85 (15) 11/35 (31) 
 5-year mortality rate 15/85 (18) 14/35 (40) 
OPEN REPAIR 0,46 
 30-day mortality rate 1/97 (1) 0/8 (0) 
 1-year mortality rate 9/97 (9) 1/8 (13) 
 2-year mortality rate 13/97 (13) 1/8 (13) 
 3-year mortality rate 19/97 (20) 1/8 (13) 
 5-year mortality rate 26/97 (27) 1/8 (13) 
Data are presented as n and (%), unless otherwise specifi ed.
EVAR=Endovascular aneurysm repair; Group I= patients between 70-79 years; Group II=patients 80 years or older.
*Calculated by Chi-square test
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Figure 2. Kaplan Meier curve of survival 
after conservative treatment.
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Figure 3. Kaplan Meier curve of survival 
after EVAR.
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Figure 4. Kaplan Meier curve of survival 
after OPEN repair.
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Treatment
EVAR
Four articles assessed mortality rates after EVAR. [18-21] These articles reported on patients aged 
60 years and older undergoing EVAR as elective AAA treatment. Some articles (n=2) focussed 
specifi cally on “high risk” patients. High-risk criteria in these studies included age ≥ 60 years, 
ASA classifi cation 3 or 4 and the comorbidity variables of history of cardiac, respiratory, or 
hepatic disease, cardiac revascularization, renal insuffi  ciency, and low serum albumin level. 
[19,20]
The studies showed low perioperative mortality rates, ranging from 0,9% to 6%. [18, 20,21] 
However, this was higher compared to younger patients. [21] Two-year survival rates ranged 
from 68% to 84%.
EVAR in octogenarians resulted in acceptable midterm survival rates. [21] Age should there-
fore not be an exclusion criteria for EVAR and therefore EVAR can be an alternative for OPEN 
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Figure 5. Study fl ow and exclusion criteria.
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repair in elderly patients. [18,21] Also, in “high risk” patients EVAR for AAA was justified with a 
2-year survival rate of 84%. [20] In contrast, one study demonstrated no benefit in midterm 
outcome in patients ≥ 75 years and treated with elective EVAR. [19]
OPEN vs. EVAR
Four articles compared mortality rates between EVAR and OPEN. [22-25] The best treatment 
option for elective AAA in high-risk patients remains unclear, as the different papers report 
in contrast to each other: comparable mortality rates after EVAR and OPEN repair up to 4 
years [22] versus lower 1-year mortality rate after EVAR compared to OPEN repair [24] versus the 
opposite. [25]
Conservative
One article reported on conservative treatment of asymptomatic AAA that met the treatment 
criteria in “high risk” patients unfit for surgery. [26] They concluded that aneurysm rupture rate 
is relatively high among conservatively treated patients unfit for surgery. Given the fact that 
5 out of 12 patients survived the ruptured AAA operation, they state that operative manage-
ment in these patients should be considered.
DISCUSSION
This study demonstrates higher mortality after conservative treatment of an abdominal 
aortic aneurysm that meets the treatment criteria as compared to EVAR in the extreme fragile 
elderly patients. Despite this finding, the survival of these fragile patients is 45% after two 
years. So, there may be a place for conservative (no operation) treatment in fragile patients 
unfit for surgery with an AAA. Another important finding was the fact that mortality after 
endovascular treatment of AAA in patients aged 80 years and older was significantly higher 
compared to the younger group, while no differences between age groups were measured in 
the conservative and OPEN group.
Elective treatment of AAA in the elderly is more common as a result of an aging population 
and the increasing use of CT scans detecting incidental AAAs. [27] However, there is still little 
data available on outcomes of EVAR and open repair in elderly patients. EVAR has become 
the treatment of choice in patients not eligible for open repair. [1,4] Patients undergoing EVAR 
are supposed to have fewer complications, shorter hospital stay, and earlier return to their 
function compared to patients treated with open repair. [4] Earlier studies demonstrated EVAR 
as a safe procedure to manage AAA in the elderly with a 30-day mortality rate of less than 2%. 
[26-29] Our study shows similar results in short-term survival. However, long-term survival is not 
taken into account in these studies. EVAR has been demonstrated to reduce mortality and 
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complication rates in the fi rst month after the procedure compared with open repair. [5,30,31] 
Although EVAR is less invasive than open repair, endoleaks and endograft failure leads to a 
greater number of re-interventions. [30] Especially in elderly patients, these re-interventions 
have more impact on their general health. Raval et al. concluded that EVAR is superior to 
open repair in octogenarians and must be the treatment of choice in these patients. [27] In 
contrast, our study shows that patients aged 80 years and older had poorer survival com-
pared with younger patients after EVAR, but not after open repair. Furthermore, we found 
worse survival after EVAR in octogenarians as compared to open repair. To this last conclusion 
should be noted, however, that the group octogenarians who underwent an OPEN repair was 
very small.
The EVAR-1 trial showed similar overall mortality rates in patients after undergoing EVAR and/
or open repair of an AAA. [5] EVAR was postulated as a minimally invasive approach of an AAA 
in patients unfi t for major surgery. But the EVAR-2 trial showed no survival benefi t for EVAR 
compared with conservative management and concluded EVAR was not a safe procedure 
in high-risk patients. [32] Additional to these results we found signifi cantly worse survival in 
octogenarians undergoing EVAR compared to younger patients.
Particularly in a population of patients with shorter life expectancy it remains important to 
focus on quality of life as an important outcome measurement. This study does not report 
about the quality of life after operative or conservative treatment of an AAA. Earlier, the EVAR 
1 and 2 and the DREAM trial reported confl icting results on outcome of quality of life after 
EVAR and open repair. [5,28,30,32] They all reported decrease in quality of life after EVAR and open 
repair of AAAs. These studies do not describe the feasibility of conservative management of 
certain patients sustaining an AAA.
Our systematic review showed acceptable midterm survival rates after EVAR in octogenarians. 
[21] Age should therefore not be an exclusion criteria for EVAR and therefore EVAR can be an 
alternative for OPEN repair in elderly and fragile patients. [18,20,21] However, The best treatment 
option for elective AAA in high-risk patients remains unclear, as the diff erent papers report in 
contrast to each other. [20, 22-25]
Because of its retrospective nature, our study has limitations, which should be considered 
when interpreting the results. First, a limitation of this study may be the restriction of data 
collection from only one hospital, which might not be completely representative for all hos-
pitals. Second, the number of patients in the present study does not permit further analyses 
in dept. Third, this is an observational study on the outcome of AAA management in the 
elderly patients, it does not give an answer on the question which patients should receive 
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treatment and what kind of treatment. However, this observational study describes some 
important outcomes that can help us in further studies on this topic.
CONCLUSION
There are specific guidelines for the treatment of AAAs. These guidelines are based on the 
degree of dilatation of the aorta. However, patient general health, age and comorbidity 
are not taken into account in these guidelines. On the basis of our study we can’t make a 
clear statement about the best treatment of AAA in elderly patients. We are aware that the 
definition of AAA is important in this matter. Asymptomatic AAA with diameters equal to or 
slightly larger than the treatment criteria can more easily be managed conservatively. We 
believe that patient selection could be the key to improve results of aneurysm treatment 
in the elderly population. However, very elderly fragile patients with AAA remain a difficult 
group to treat. A good risk analysis based on comorbidity, risk of rupture and mortality due 
to surgery is of great importance in these patients, but the desire of the patient remains the 
guiding principle.
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ABSTRACT
Background: Age-related issues are expected to rise in the coming decades. Osteoporosis, 
falls and fractures are major public health issues among elderly. Pelvic fractures are associ-
ated with a serious morbidity and hospitalization rate. We therefore performed a study to 
determine trends in incidence and age-specific rates of pelvic fracture related hospitaliza-
tions amongst elderly (≥65 years).
Methods: A secular trend analysis of all hospitalizations due to a pelvic fracture among older 
adults, using the National Medical Registration, 1986-2011, The Netherlands.
Results: The total number of hospitalizations due to a pelvic fracture increased from 887 
in 1986 to 2,013 admissions in 2011 (127% increase). The overall age-adjusted incidence 
rate increased from 5.19 in 1986 to 7.14 per 10,000 population in 2011 (37.5% increase). 
The incidence rate increased with age and was higher for females. The Percentual Annual 
Change (PAC) was 1.2% (95%CI 0.9;1.5) for older males, and 1.0% (95%CI 0.9;1.2) for females, 
respectively. The mean length of hospital stay decreased between 1991 and 2011 to 12.0 
days (53.4% decrease). The total number of hospital-bed-days decreased from 29,002 days 
in 1991 to 17,283 days in 2011 (40.4% decrease), despite an increase in absolute number of 
admissions.
Conclusion: Absolute numbers and incidence rates of pelvic fractures are increasing among 
the older Dutch population. Considering the fact the general population is growing older, an 
increasing number of elderly suffer from pelvic fractures. Attention on osteoporosis screen-
ing and prevention of falls in elderly remains important, in order to limit related healthcare 
costs in the future.
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INTRODUCTION
The population of older adults, aged 65 years and over, is increasing rapidly worldwide.(1) The 
increase of the older population is partly caused by a rising number of older adults, but also 
due to an increasing life expectancy. Consequently, age-related problems are rising, includ-
ing osteoporosis and falls.(2, 3) Falls are the main cause of injuries among older adults, and 
leading to a high healthcare demand. One-third of the persons aged 65 years and older fall 
on average once a year.(4, 5) The majority of fall-related injuries among older adults, presenting 
at an Emergency Department, are fractures (60%) and superfi cial injuries (21%).(6) It might 
be expected that rates of pelvic fractures will increase in the near future.(7, 8) Fractures of the 
pelvic bones are associated with high rates of hospitalization and mortality.(9)
Worldwide, osteoporosis is a growing public health issue in developed countries.(10) People 
with osteoporosis, characterized by low bone mass and micro-architectural deterioration 
of bone tissue, have an increased risk of fractures.(11) Over 60% of the pelvic fractures are 
associated with osteoporosis. For patients aged 60 years and older the percentage increases 
to 94%.(12)
Accurate numbers and trends over time are needed to assign the limited healthcare re-
sources in ageing populations. The Netherlands is an ideal country for such trend analysis, 
because of the extensive and long-term registration of all hospitalizations. Therefore, the aim 
of the current study was to provide secular trend analysis of numbers, incidences and age-
specifi c rates of pelvic fractures hospitalizations among the older Dutch population.
PATIENTS AND METHODS
For this study, all hospitalizations due to a pelvic fracture among older adults were obtained 
from 1986 throughout 2011. During the study period, a pelvic fracture has been defi ned 
using the International Classifi cation for Diseases, 9th revision (ICD 9) of the World Health 
Organization, code 808.(13) Persons aged 65 years and older were defi ned as ‘the older popula-
tion’. The method used in this study, has been used previously.(14, 15)
Data were obtained from National Medical Registration (LMR, Dutch Hospital Database, 
Utrecht), which is operated by the Consumer and Safety Institute, Amsterdam, The Nether-
lands.(16) In the LMR database information is stored of nearly all hospital admissions in The 
Netherlands with a uniform classifi cation system, and with a high national coverage (missing 
values <5%, except in 2007 when 12% was missing). Data were extrapolated to full national 
coverage by the Consumer and Safety Institute. The extrapolation factor was based on the 
adherence population of the registering hospitals and the national Dutch population in each 
year of the study.(16) Information regarding hospital admissions, admission diagnosis, age, 
gender and length of hospital stay (LOS) in days is stored in this database. For each individual 
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patient only one injury code, the primary diagnosis, was used. The primary diagnosis is based 
upon the medical record of the treating physician (in general the most severe injury). During 
the study period the uniform classification and coding system for all hospitals used by the 
LMR did not change.
Numbers of hospitalizations due to a pelvic fracture were specified for age and gender. 
Demographic numbers were obtained from the Statistics Netherlands using the mid-year 
population numbers. (17) Incidence (crude- and age-adjusted) rates were calculated in 5-year 
age groups, for both males and females and expressed per 10,000 persons in the specified 
age groups. Age-adjusted incidence rates enabled us to compare the incidence rate for a 
standardized population during the study period. Demographic changes throughout the 
study period were corrected by “Direct Standardization”. Numbers of hospital admissions and 
LOS in the period 1986 throughout 2011 were expressed as percentages compared to the 
index year 1986.
The medical ethical review board of the Erasmus MC, University Medical Center, Rotterdam, 
approved the study method (MEC-2010-402) and provided a waiver for ‘informed consent’, 
because the data were retrieved from a large public accessible database, containing anony-
mous data on admissions, which cannot be traced to individuals.
A linear regression model with Poisson error and log link (log was mid year population size 
in each year of the study) as offset factor was used to model the trend in hospitalizations. The 
parameter for calendar year, corrected for gender and age group, was transformed into Per-
centual Annual Change (PAC). The Statistical Package for the Social Sciences (SPSS) software 
(version 16.1.1) was used to perform all statistical analyses. A P-value <0.05 was considered 
statistically significant.
RESULTS
During the study period from 1986 until 2011 a total number of 34,307 patients, aged 65 
years and older, had a pelvic fracture requiring hospitalization in the Netherlands. The annual 
number hospitalizations due to a pelvic fracture increased with 127% (from 887 admissions 
in 1986 to 2,013 admissions in 2011), Figure  1. The male-female ratio remained stable 
throughout the study period to approximately 1:4 (Table 1). During that same period, the 
population aged 65 years and older, increased from 1.77 million in 1986 to 2.595 million in 
2011 (46.7% increase).
Gender and age-specific incidence rates for pelvic fractures are shown in Table 2. The 
incidence rates for females are higher than those for males, and increased with age for both 
genders. The overall age-adjusted incidence rate of hospitalizations related to a pelvic frac-
ture increased from 5.19 per 10,000 population in 1986 to 7.14 per 10,000 population in 2011 
(37.5% increase). For males, the age-adjusted incidence rate increased from 2.83 per 10,000 
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Figure 1. Total number of pelvic fracture related hospitalizations and age-adjusted incidence in persons 
aged 65 years and older, The Netherlands, 1986-2011.
Incidence rate is expressed per 10,000 older population. Dashed bars indicate a fi tted regression line (P<0.001 
for both males and females).
Table 1. The number of people aged 65 years and older, and pelvic fracture related hospitalizations in The 
Netherlands, 1986-2011
Charactaristic 1986 1991 1996 2001 2006 2011
Population (*1,000) 1,769 1,934 2,061 2,175 2,330 2,595
Female sex (%) 59.9% 60.2% 59.8% 58.9% 57.6% 56.0%
No. of admissions 887 1,125 1,357 1,184 1,464 2,013
Male, No. (%) 200 (23) 235 (21) 269 (20) 254 (21) 309 (21) 343 (17)
Incidence rate* 5.0 5.8 6.6 5.4 6.3 6.9
Admission duration, d n.a. 25.8 19.5 18.1 13.1 12.0
No.. Number; *Crude incidence rate per 10,000 population aged 65-years and older; d, days; n.a., not available
Table 2. Age-specifi c incidence rates of pelvic fracture related hospitalizations in persons aged 65 years 
and older, The Netherlands, 1986-2011
65-70 y 70-75 y 75-80 y 80-85 y 85-90 y 90-95 y
Period Male Female Male Female Male Female Male Female Male Female Male Female
1986-1988 0.9 1.7 1.6 4.0 2.9 6.5 4.9 12.0 8.2 18.7 14.9 28.8
1991-1993 1.4 2.0 1.8 4.3 3.6 8.1 6.3 13.4 7.6 20.2 23.3 34.4
1996-1999 1.4 2.2 2.1 4.2 3.2 8.0 7.3 14.9 7.8 23.1 17.6 33.0
2001-2004 1.4 1.5 2.0 4.0 3.0 6.2 5.4 12.7 7.9 19.9 19.5 27.8
2006-2008 1.3 1.5 1.9 3.3 3.0 7.3 6.2 14.2 11.6 25.6 23.6 42.9
2009-2011 1.7 2.3 2.6 4.2 3.8 9.1 7.5 17.7 12.2 27.5 21.0 54.4
PAC
(95%CI)
1.7%
(0.9;2.5)
0.2% 
(-0.5;0.8)
1.4% 
(0.7;2.2)
-0.5% 
(-1.0;-0.1)
0.5% 
(-0.2;1.2)
0.6% 
(0.2;1.0)
1.0% 
(0.3;1.6)
1.1% 
(0.8;1.4)
2.0% 
(1.2;2.9)
1.5% 
(1.2;1.9)
1.5% 
(0.5;2.5)
2.3% 
(1.9;2.8)
Incidence rate is expressed per 10,000 older population. PAC, Percentual Annual Change; 95%CI, 95% Confi dence 
Interval
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persons in 1986 to 3.68 per 10,000 persons in 2011 (30.0% increase). For females an increase 
was observed from 6.82 to 9.53 (39.7% increase) during the same period (Figure 1).
Age-specific hospitalization rates increased during the study period for both genders, in 
all age-categories (Table 2). The strongest rise in age-specific incidence was seen among 
persons aged ≥85 years (Figure 2). The Percentual Annual Change (PAC) was 1.2% (95%CI 
0.9;1.5) for the older male population. For females the PAC was 1.0% (95%CI 0.9;1.2) during 
the study period. The PAC for the age-specific groups are shown in Table 2. There was a shift 
in the distribution of the different age-groups. The proportion of oldest old, persons aged 85 
years and older, increased during the study period (Figure 3).
The mean admission duration among older adults admitted because of an pelvic fracture 
decreased over the last 20 years for all age-groups, from 25.8 days in 1991 to 12.0 days ad-
mission in 2011 (Table 1). Despite an increase in the total number of pelvic fracture related 
hospitalizations, the total number of hospital-bed-days decreased from 29,002 days in 1991 
to 17,283 days in 2011 (40.4% decrease), due to the decrease in the mean admission duration. 
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Figure 2. Age-specific incidence rate of pelvic fracture related hospitalizations in The Netherlands during 
the period 1986-1988 and 2009-2011.
Incidence rate is expressed per 10,000 population.
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Figure 3. Proportion of different age group admitted with a pelvic fracture in The Netherlands, 1986-2011.
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In older males, it decreased from 7,857 days in 1991 to 4,745 in 2011 (decrease 39.6%). For 
females an decrease was seen from 21,145 days in 1991 to 12,537 hospital-bed-days in 2011 
(decrease 40,7%), Figure 4.
DISCUSSION
In the current study secular trends of pelvic fracture related hospitalizations in the older 
Dutch population are shown. Both absolute numbers and incidence rates are increasing. 
However, the total number of required hospital-bed-days decreased during the study period 
due to a reduced length of hospital stay per admission.
Melton et al. reported an exponentially increase in the incidence of pelvic fractures in the 
USA in both elderly men and women.(18) Kannus et al. reported similar results in Finland over 
the period 1970-1997.(19) These fi ndings are in concordance with our results. Pelvic fractures 
comprise less than 5% of all fractures in patients aged 80 years and older. However, these 
fractures constitute up to 23% of admissions to level 1 trauma centers in the USA. (20) Also, 
Matityahu et al. reported an increased rate of severe complications (e.g. renal failure, acute 
respiratory distress syndrome or pulmonary embolism) and mortality among the oldest old 
(80 years and older) with pelvic fractures.(21)
Because the population of older adults is increasing and the life expectancy is increasing, 
the proportion of older adults will increase in the next decades. The incidence of fragility 
fractures might be predicted to show a similar increase.(1) Related healthcare demands and 
healthcare costs are expected to show a comparable rise in the coming decades, on top of 
the rising incidence rates.
One of the most important factors of the related healthcare resources and costs, is the LOS 
per admission Over the last decades the admission duration has been reduced by over 50%. 
The reduction in LOS may, at least partly, be explained by better pain management and bet-
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Figure 4. Total number of hospital-bed-days due to pelvic fracture related hospitalizations in The Nether-
lands, 1991-2011.
Dashed bars indicate a fi tted regression line (P<0.05 for all groups).
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ter care during hospital stay with early mobilization under supervision of the physiotherapist. 
Also, early discharge to designated rehabilitation places and skilled nursing homes have con-
tributed to this reduction in LOS.(22) The mean admission duration related to pelvic fractures 
was longer for patients who were not self-sufficient prior to the fracture. Furthermore, the 
high LOS can be attributed to complications associated with immobility. These complica-
tions are decreased muscle strength, deep venous thrombosis and pulmonary embolism, 
postural hypotension, decreased cardiac function, urinary retention and calculus formation, 
constipation, pressure ulcers, impaired pulmonary function resulting in pneumonia, and 
bone resorption with worsening osteoporosis.(12)
In The Netherlands all inhabitants enjoy a full health care insurance and full accessibility to 
the Dutch health care system. This system has been applicable during the whole study period. 
The study has been based on data retrieved from the electronic national population-based 
in-hospital data from 1986 until 2011. This highly accurate electronic database records with 
nearly complete national coverage all pelvic fractures related hospital admissions as well as 
hospital- bed- days in all hospitals in the Netherlands. It is important to mention that during 
the study period no changes in the coding system of the National Medical Registry occurred, 
nor were there major policy changes introduced affecting the increase in admission rates.
However, this study has a few notable limitations. First of all, linked administrative 
databases are prone to variation and coding errors. (23) A quality survey performed in 2002 
by Paas et al, showed a high accuracy of coded injury data of the LMR database (correctly 
coded in 91% of cases and in 9% incomplete). (24) These data are comparable of a similar data 
registration from New Zealand (period 1996-1998). (25) The true number of pelvic fractures 
might be higher, because only the primary admission diagnosis was used. So in patients with 
multiple, more severe injuries were missed in this study. Furthermore, the database used 
does not contain clinical data regarding underlying diagnosis and co morbidities. Also no 
data were available as far as injury severity, lifestyle or medication of patients. Therefore the 
interpretation of causal mechanisms behind observed trends is limited. Possible explana-
tions for the observed trends might be that the population is ageing, individuals are longer 
living independently, and with more comorbidities. Consequently, these people remain more 
mobile and the fall risk increases. Retrieved data only relates to patients in the Netherlands, 
the results may not be directly translated to other countries, as other healthcare system and 
different demographics may exist. Furthermore, readmissions were not excluded and some 
“double registration” could have occurred. However, it is unlikely that readmissions influenced 
our results, because readmissions constitute only 2.6% in the Netherlands, as was found in a 
study by Polinder et al..(26)
In conclusion, absolute numbers and incidence rates of pelvic fractures increased in the 
Netherlands. During the study period incidence rates increased with almost 50% in patients 
aged 65 years and older. However, the total number of hospital-bed-days was almost halved 
in the same period. As the general population is ageing, an increasing number of older 
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patients suff er from pelvic fractures. In order to limit related healthcare costs in the future, 
it remains important to keep attention on the prevention of falls and osteoporosis among 
older adults.
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ABSTRACT
Background: More than 75% of all patients presenting with a proximal humerus fracture are 
70 years or older. Very little is known about the outcome after operative treatment of these 
fractures in very old patients. This study was performed to gain more insight in safety and 
functional outcome of surgical treatment of proximal humerus fractures in the elderly.
Materials and Methods: In this observational study, we analyzed all operatively treated pa-
tients, aged 75 years or older, with a proximal humerus fracture between January 2003 and 
December 2008 in our center. Patient selection was on clinical grounds, based on physical, 
mental and social criteria. Complications were evaluated. We used the DASH Questionnaire 
to investigate functional outcome, pain and ADL limitations.
Results: Sixty-four patients were treated surgically for a displaced proximal fracture of the hu-
merus, 15 two-part, 32 three-part and 17 four-part fractures. Mean DASH scores in them were 
37.5, 36.9, and 48.6, respectively. Regarding the operative methods, overall good results were 
obtained with the modern locked plate osteosynthesis (Mean DASH 34.4). Prosthetic treat-
ment, mostly used in highly comminuted fractures, often resulted in poor function (Mean 
DASH 72,9). Persistent pain and ADL limitations were more present in more comminuted frac-
tures (64 and 50% in patients with 4-part fractures vs 14% in patients with 2-part fractures). 
There were no postoperative deaths within three months of surgery, and fracture-related and 
non-fracture-related complication rates were low (non-union 3%; 1 myocardial infarction). 
Conclusions: This study shows that it is safe and justifiable to consider surgical treatment of a 
severely dislocated proximal humerus fracture in selected patients aged 75 and older.
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INTRODUCTION
Up to 80% of fractures of the proximal humerus are suitable for conservative management, 
with the use of a sling and physical therapy. [1] However, if severe fracture dislocation is 
present, poor functional outcome of conservative treatment can be anticipated and surgical 
intervention must be considered. With the advent of more advanced implants and improved 
surgical techniques, surgical interventions for these fractures are gaining more acceptance. 
Possible advantages include faster mobilization, less pain, and better functional outcome. 
This is particularly true for younger patients. [2]
However, to our knowledge, there is no specifi c report about the outcome of surgically 
treated fractures of the proximal humerus in the very old patient.
In the older population, fractures of the proximal humerus are most common, after hip and 
wrist fractures. The incidence in patients over 70 years reaches up to 9 per 1000 population/
year. This represents more than 75% of all proximal humerus fractures. [3,4]
Especially in view of the ever increasing elderly population, insight into functional out-
come in this group is very important. Challenges in treating this population operatively are 
the presence of osteoporosis, higher risks for surgery and the diffi  culties in rehabilitation. 
Knowledge of the functional outcome in these patients may help in making the best choice 
of treatment in terms of quality of life and health care costs, giving them a chance to maintain 
an independent lifestyle.
This study was performed to gain more insight in the outcome, regarding postoperative 
mortality, pain, Activities of daily life (ADL) limitations, and functional outcome of surgically 
treated fractures of the proximal humerus in patients aged 75 years and older.
MATERIALS AND METHODS
This observational study was based on a single-centre retrospective research.
All patients operatively treated for fractures of the proximal humerus, from the age of 75 
years and older between January 2003 and December 2008 were included in order to have 
at least 12 months of follow up. [5] The selection for operative treatment was fi rst based on 
the confi guration of the fracture, of which dislocation of fragments of the fracture is most 
important. Second, this selection was based on careful clinical judgment of the treating 
surgeon, considering the physical, mental and social condition of the patient. We excluded 
patients from the study who presented 14 days or more after injury, and patients with mul-
tiple fractures of the upper extremity. A total of 64 surgically treated patients were included, 
with an average age of 80.1 years (SD 3.8) at the time of injury. At the time of the research, 13 
patients were lost to follow-up: 10 patients had died and 3 cases lacked contact information. 
Mean follow-up time was 3.7 years (SD 1.4).
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Patient characteristics comprised age, gender, affected side, follow-up period, age at 
injury, risk of surgery as reflected by ASA-classification [6], and operative technique. Fracture 
classification was performed according to Neer. [7] This classification is primarily based on the 
number of main fracture fragments.
Various surgical techniques for reconstruction of the fracture were used. The most 
frequently applied techniques were open reduction and internal fixation (ORIF) using a 
locking compression plate (the Proximal Humeral Locking Plate (PHLP) or the Philos Plate, 
both Synthes, Switzerland), ORIF using K-wires and a tension band construction, or hemi-
arthroplasty prosthetic repair (either the Global prosthesis, Johnson & Johnson, USA or the 
Articula prosthesis, Matthys, Switzerland). The choice for a specific operative technique was 
based on several factors: first, patient-related factors, such as frailty and more advanced age, 
were more often reason to use a less invasive operative technique such as ORIF using K-wires 
and a tension band construction; second, surgeon-related factors, such as more experience 
or education in one specific operative technique; and third, as the study progressed, the use 
of locking compression plates became more popular.
Postoperative rehabilitation protocol consisted of protected active and passive circumduc-
tion exercises during the first 4 weeks under supervision of a physiotherapist. Progressive 
active mobilization after 4 weeks was initiated when control X-rays were satisfactory and 
showed a stable and unchanged osteosynthesis.
Mortality and fracture-related complications such as nerve damage, wound infection and 
non-union were recorded. Also, relevant non-fracture-related complications, such as cerebro-
vascular accidents, sepsis or thromboembolic disease were researched from the patient files.
We used the DASH Questionnaire (Disability of Arm, Shoulder and Hand) to investigate 
functional outcome in 51 patients. The scores retrieved from the Questionnaires vary from 0 
(a perfect function) to 100 (complete loss of function of the injured limb). Patients with severe 
psychiatric of physical impairment at follow up, could not be investigated by this questionnaire 
and were excluded from further analysis (n=8). A selection of the questions regarding pain and 
ADL limitations, were used to evaluate pain and ADL limitations as outcome measures.
RESULTS
In the 5-year period between January 2003 and December 2008, 64 patients aged 75 years or 
older, were treated surgically for a proximal fracture of the humerus. Patient characteristics 
are listed in Table 1. Ten patients were deceased by the time of this research, with a mean of 
22 months after diagnosis (SD 18 months).
This population consisted of 15 patients with a two-part, 32 patients with a three-part, and 
17 patients with a four-part displaced fracture of the proximal humerus.
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ORIF using LCP osteosynthesis was used in 24 patients (7 two-part, 16 three-part, 1 four-
part). ORIF with a tension band construction technique in 15 patients (2 two-part, 10 three-
part, 4 four-part). In this group, 8 patients required re-operation due to secondary dislocation. 
A hemi-arthroplasty was performed in 16 patients (4 three-part, 12 four-part). Nine patients 
were treated with the use of other surgical techniques for internal fi xation: intramedullary 
nail (n=4), single lag screws (n=3) or conventional (non-LCP) plate osteosynthesis (n=2). The 
exact distribution of the patients among the groups is set out in Table 3.
In this very old patient cohort, selected on clinical criteria of vitality, there were no postop-
erative deaths within three months of surgery. One patient developed a myocardial infarction 
postoperatively. Three patients were treated successfully for a urinary tract infection. Wound 
infection occurred in 1 patient and axillary nerve damage in 1 other patient. Osteonecrosis 
of the humeral head was not observed in this population. A non-union was observed in 2 
patients treated with ORIF using LCP osteosynthesis (3%). Eight out of the 15 patients initially 
treated with ORIF using K-wire and a tension band wire required re-operation due to second-
ary dislocation. In these re-operated patients, neither mortality nor additional morbidity was 
observed.
In the evaluation of functional outcome in these patients, 43 patients were eligible for analy-
sis. The mean DASH score in patients with a two-part fracture was 37.5 (n=7), in patients with 
a three-part fracture 36.9 (n=22). Patients having suff ered a four-part fracture did signifi cantly 
worse with a mean DASH score of 48.6 (n=14). Also the occurrence of moderate to severe pain 
and limitations in ADL increased signifi cantly with increasing number of fracture parts. (table 2)
Analysis of the results according to the operative methods showed an interesting trend 
(Tables 2, 3). Mean DASH score in ORIF using either a LCP device (n=17), or a tension band 
wire technique (n=9), in spite of necessary re-operations was 34.4 and 33.9, respectively. 
Hemiarthroplasty patients fared less well, their mean DASH score was signifi cantly higher 
with 53.9 (n=14). Moderate to severe pain and ADL-limitations were signifi cantly less present 
(12 and 18%, respectively) in patients treated with LCP.
Table 1: Patient characteristics
All % or (SD) Functional 
Follow-up
% or (SD)
Patients 64 100 51 67
Age, mean 80.1 (3.8) 81.8 (4.3)
Gender: Female 58 91 48 94
Aff ected side: Right 26 41 15 38
Psychiatric/physical impairment 8 12 8 16
ASA Score, mean 2.4 (0.8) 2.3 (0.8)
Deceased 10 6.4 - -
 Days after surgery 670 (547) - -
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Table 2: DASH, pain and ADL-limitation by fracture classification and surgical technique
Number 
of 
patients
DASH Moderate/severe 
Pain (%)
Moderate/Severe 
ADL Limitations (%)
Fracture classification:
 2-part 7 37.5 1 (14) 1 (14)
 3-part 22 36.9 7 (32)* 9 (41)*
 4-part 14 48.6* 9 (64)** 7 (50)*
Surgical technique:
 LCP 17 34.4 2 (12) 3 (18)
 K-wire/Tension band 9 33.9 5 (56)* 5 (56)*
 Hemi-arthroplasty 14 53.9* 8 (57)* 7 (50)*
* P-value <0.05; ** P-value <0.001
Tabel 3. Detailed report of the study cohort
Neer N 
included
N
follow-up
repair N 
included
N
follow-up
Mean 
DASH
Moderate/ 
severe pain
ADL 
limitations
2part 15 7 LCP 7 3 31.4 0 0
K-wire/ tension band 2
(1x reop)
1
(1x reop)
36.7 0 0
Hemi-arthroplasty 0 - - - -
Nail 3 2 65.4 1 1
Lag screws 2 1 13.3 0 0
Non LCP 1 0 - - -
3part 32 22 LCP 16 13 36.4 2 3
K-wire/ tension band 10
(7x reop)
6
(3x reop)
39.7 3 4
Hemi-arthroplasty 4 2 22.9 1 1
Nail 1 0 - - -
Lag screws 1 0 - - -
Non LCP 1 1 56.6 1 1
4part 17 14 LCP 1 1 0 0 0
K-wire/ tension band 4
(0x reop)
3 20 2 1
Hemi-arthroplasty 12 10 60.1 7 6
Nail 0 - - - -
Lag screws 0 - - - -
Non LCP 0 - - - -
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DISCUSSION
Data in the current literature suggest that operative treatment of displaced proximal humerus 
fractures may have a better outcome compared to conservative treatment, but convincing 
evidence is not available. Especially in the older patients, considerable pain and functional 
limitations remain after both treatment modalities. [1, 2, 9-11]
The aim of this research was twofold. First, it was performed to study whether our policy 
of operative fracture management of the proximal humerus fracture in the very old, after 
deliberate and careful selection, was safe in terms of mortality and morbidity. Second, it was 
undertaken in order to study whether the functional results justifi ed operative treatment of 
proximal humerus fractures in older patients. Of course, the fi rst aim was of primordial im-
portance; even if the results after surgery would be excellent and far better than conservative 
treatment, an elevated risk of mortality would raise considerable questions about a justifi ed 
indication.
All patients in this study were operated only after careful selection on clinical grounds. All 
somatic risk factors were taken into account in our clinical judgment. Many patients included 
in this study, had cardiovascular or pulmonary comorbidities, as might be expected in this 
old population. However, patients considered not fi t for surgery were treated conservatively 
with use of a sling. We would like to emphasize that mental vitality and social independency 
of the patients were also important factors in the decision making to perform surgery in 
case of a shoulder fracture. In this study, no patient died within 3 months of the operation 
or re-operation. This suggests that it is safe to perform this surgery in well-selected patients.
In a previous report by Owsley, locked plate fi xation of humeral fractures in patients older 
than 60 years was associated with a high rate of screw cutout and revision surgery.(6) Surpris-
ingly, the number of fracture- and non-fracture-related complications in our study was very 
low. Also in this regard, surgery of the shoulder in the selected very aged patients appeared 
to be safe.
Furthermore, the functional results of operative repair in general were satisfactory. As is 
known from the literature, the functional prognosis is worse as the number of fracture frag-
ments increases: 4-fragment fractures generally fare much worse than 2- or 3-part fractures, 
whether treated conservatively or operatively.(7) This also appeared to be true in this cohort of 
elderly patients: The postoperative results of the 2- and 3-part fractures were satisfactory to 
good in most patients, with a mean DASH score in these groups of 37.5 and 36.9 respectively 
(Table 2). Four-part fractures, often treated with a hemi-arthroplasty, generally had a poor 
postoperative course with a mean DASH score of 53.9.
As to the type of osteosynthetic repair, some interesting fi ndings were noted. Especially 
in the patients treated by ORIF with locked compression plates, adequate pain reduction 
and functional recovery was achieved. Although the tension band group seemed to do quite 
well, it should be kept in mind that these results were obtained after half of these patients 
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were re-operated. An extra operation in this group of patients is, of course, not desirable 
considering the perioperative risks. The tension band technique is often used for the treat-
ment of unstable fractures by less experienced surgeons or in patients who were older or had 
more comorbidities, since it is less invasive, which resulted in re-dislocation of the fracture 
fragments in some cases. Often, the re-operations were performed by more experienced 
surgeons, resulting in an eventually good result. Fortunately, these re-operations did not 
cause further mortality or morbidity, and ended with good results.
In the studied population, pain experience, ADL limitations and the overall functional 
outcome as measured by the DASH score, is significantly worse after hemiarthroplasty com-
pared to internal fixation. This finding is consistent with the results of prosthetic repair in 
younger groups [2] Hemi-arthroplasty was predominantly used in severely displaced and/or 
highly communitive fractures of the proximal humerus. Our rationale for operation was that 
highly communitive and dislocated fractures of the proximal humerus, especially in case of 
a luxated and avascular humeral head, warranted a prosthetic repair. The use of prosthetic 
repair was primarily intended for minimizing pain rather than regaining function. However, 
our study showed that severe pain often persists after hemiarthroplasty. It would be interest-
ing to know how these patients would have fared with conservative treatment.
This study shows that it is safe and justifiable to perform osteosynthetic repair of a severely 
dislocated proximal humerus fracture in selected patients of 75 years and older. This might 
diminish pain and ADL limitations and potentially contribute to the preservation of an inde-
pendent lifestyle.
Further research is needed to elucidate the true impact on quality of life of the very old 
patient, and to identify specific groups of patients or fracture types that are less suitable for 
surgical treatment.
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ABSTRACT
Background: Hip fractures in the elderly population are associated with high morbidity and 
mortality. However, there is still a lack of information on mortality and loss of independency 
in extremely elderly people with a hip fracture.
Objective: To study functional outcome and mortality after osteosynthesis of hip fractures in 
very old patients in our clinic.
Patients and Methods: Hospital charts of all patients over 90 years old operated for a hip 
fracture between January 2007 and December 2011 were reviewed. Outcome measures were 
mortality, preoperative and postoperative mobility, and loss of independency.
Results: A total of 149 patients were included, 132 (89%) women, median age 93,5±2,45 years. 
Thirty-six (24%) patients were classified as American Society of Anesthesiologists (ASA) grade 
2, 104 (70%) as ASA 3 and nine (6%) as ASA grade 4. The Charlson comorbidity index (CCI) 
score was 2 or less in 115 (77%) patients and 34 (23%) patients scored 3 of more points. 
Short-term survival was 91% and 77% on 30-day and 3-months, respectively. Long-term 
survival was 64%, 42% and 18% at 1-, 3- and 5 years after surgery, respectively. Survival was 
significant better in patients with lower ASA score (P=0.005). No significant difference in 
survival was measured between patients according CCI score (P=0.13). Fifty-one percent of 
patients had to be accommodated in an institution with more care following treatment, and 
57% was less mobile after osteosynthesis of a hip fracture.
Conclusion: Our study shows that short-term mortality rates in very elderly patients with a 
hip fracture are high and there is no clear predictive value for mortality. ASA classification is 
the best predictive value for overall mortality. A large proportion of these patients lost their 
independency after osteosynthesis of a hip fracture.
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INTRODUCTION
Proximal femoral fractures are an important cause of hospitalization of elderly people, cur-
rently leading to nearly half of all injury-related health care costs of aged adults in The Neth-
erlands.1 Most hip fractures (80%) occur in persons aged 65 years and older.2,3 This population 
is increasing rapidly worldwide.4 The overall 1-year mortality rate associated with hip fracture 
is reported to be between 14% to 47%.5,6 Still, there is missing data on functional outcome 
and mortality rates in extremely elderly patients.7
Demographic aging is caused by decreased fecundity along with the increasing life expec-
tancy. Consequently, age-related problems are rising, including osteoporosis and falls.1,8 Falls 
are the main cause of injury among elderly people, one-third of the persons over 65 years fall 
on average once a year, leading to a high health care demand.9,10 The majority of fall-related 
injuries that required treatment in a hospital are fractures (60%) and superfi cial injuries 
(21%).11 Older individuals in particular are at an increased risk of sustaining fractures due 
to underlying medical conditions, especially osteoporosis.12,13 Typical osteoporotic fractures 
include those of the hip, wrist, vertebrae, and upper arm.14
Hip fractures, more than any other type of fracture, are associated with loss of independence, 
morbidity, and mortality, and have a major impact on the quality of life of the patients and 
their caregivers.5,15,16,17 The care for these patients is complex and requires a multidisciplinary 
and multiagency input.5
Despite the increasing population of extremely old patients with hip fractures, data on 
mortality rates, predictive values of risk factors on mortality, and functional outcomes after 
osteosynthesis of hip fractures in these very old is still lacking. The aim of our study was 
to evaluate outcomes after osteosynthesis of hip fractures in a population of extremely old 
patients aged over 90 years.
PATIENTS AND METHODS
Study design
Patients aged 90 years and older presenting with a fracture of the hip were identifi ed retro-
spectively from January 2007 until December 2011. All patients undergoing osteosynthesis 
of a hip fracture were included. Data from patient records were collected in a database 
containing the following parameters: type of hip fracture, comorbidity scores, type of inter-
vention, time till intervention, age, clinical outcome and survival. The type of hip fracture 
was scored according the Müller AO classifi cation of fractures. Comorbidity was assessed 
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by the Charlson Comorbidity index (CCI) score.18 The CCI determines comorbidity level on 
the basis of the number and severity of 19 pre-defined conditions. It provides a weighted 
score of comorbidities, which can be used to predict short- and long-term outcomes such as 
function, length of hospital stay and mortality rates. The CCI is the most widely used scoring 
system for comorbidity used by researchers and clinicians.18 The age-adjusted variant of the 
CCI was not used, because our study population contains only patients aged over 90 years. 
The preoperative conditions of patients was also scored according to the American Society 
of Anesthesiologists (ASA) grading scale.19 The ASA physical status classification system is 
a system for assessing the fitness of cases before surgery. The American Society of Anes-
thesiologists (ASA) adopted the five-category physical status classification system; these are: 
1. Healthy person; 2. Mild systemic disease; 3. Severe systemic disease; 4. Severe systemic 
disease that is a constant threat to life; 5. A moribund person who is not expected to survive 
without the operation. Interventions were osteosynthesis of a hip fracture with a Gamma 
nail (Stryker Corporation, Kalamazoo, MI, USA), Dynamic Hip Screw (DHS) or cannulated 
screws. Furthermore, the total preoperative delay (time between fracture and surgery), and 
preoperative hospitalization delay (time between admission and surgery) were calculated. 
Development of postoperative delirium was measured using hospital records. Delirium was 
diagnosed using the Delirium Observation Screening (DOS) scale. Outcome was measured 
in terms of mortality, morbidity and loss of independency. The consequence in terms of loss 
of independency was scored according change in place of residence and/or mobility. We 
contacted patients’ general practitioner and/or place of residence to assess these variables. In 
the Netherlands, a nursing home is a place were elderly people who can’t live independently 
anymore receive help with household tasks, personal care and meals. A care home is a place 
were people receive medical care after hospital stay or in case of prolonged illness. We also 
assessed predictive values of risk factors on mortality rates. We calculated mortality at 30 
days, 3 months, 1 year, 3 year, and 5 years after intervention. Follow-up data were obtained 
from hospital records. If mortality was not reported, the general practitioner was contacted 
by the authors to determine survival.
Surgery
Patients were treated by a general or orthopedic surgeon. The type of hip fracture was 
evaluated by standard X-ray examination of the pelvis and broken hip. The type of osteo-
synthesis was determined at the discretion of the treating physician. Preoperatively, patients 
underwent cardiopulmonary and medical evaluation to estimate operative risk in order to 
optimize their general physical status if necessary. After surgery, mobilization and weight 
bearing bearing was allowed as soon as possible according to the surgeon’s advice. Patients 
started to mobilize under the supervision of the physiotherapist.
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Ethics approval
We consulted the institutional review board (Advisory commission involving Human Sub-
jects Research Amphia Hosptital - AMOA) of the Amphia hospital and they confi rmed that no 
formal written waiver for ethics approval was required, because of the retrospective design 
of the study. Also there was no written consent needed from the patients.
Statistical analysis
SPSS 19.0 for Windows package (IBM Corporation, Armonk, NY, USA) was used for the sta-
tistical analysis. Frequencies and descriptive statistics were used for reporting the baseline 
characteristics of the patient group. The chi-square test was used to determine statistical 
signifi cance.
In univariate analysis survival probabilities were calculated with the Kaplan-Meier method. 
The log-rank test was used to determine statistical signifi cance of the categorical variable 
at hand. Multivariate survival analyses were performed using the Cox proportional hazards 
model. A P-value below 0.05 was considered to denote statistical signifi cance.
RESULTS
In total 149 patients were included, 132 (89%) were women and the median age was 93,5±2,45 
years. Preoperatively, 36 (24%) patients were classifi ed as ASA grade 2, 104 (70%) as ASA 
grade 3 and 9 (6%) as ASA grade 4 according to the ASA classifi cation. The CCI score was 2 
or less in 115 (77%) patients and 34 (23%) patients scored 3 of more points, which means 
a higher level of comorbidity preoperatively (Table 1). The type of hip fractures according 
diff erent fracture classifi cations are listed in Table 2. Total follow-up ranged from less than 1 
month to 70 months (mean 23 months), during which 99 deaths were observed.
After osteosynthesis the overall survival was 91% and 77% at 30 days and 3 months, respec-
tively. Long-term survival was 64%, 42%, and 18% at 1, 3, and 5 years after surgery (Figure 1). 
When patients were divided according ASA classifi cation, overall survival was signifi cantly 
better in patients with an ASA score of 2 compared to patients with an ASA score of 3 or 
4 (P=0.005, Figure 2). No signifi cant diff erence in survival was measured between patients 
with a CCI score of 2 or less and patients with a CCI score of 3 or more (P=0.13, Figure 3). 
Mortality rates in relation to type of anesthesia (general or spinal) were not signifi cantly 
diff erent (P=0.82, Figure 4). There was no signifi cant diff erence in mortality rates between 
patients operated in 24 hours after occurrence of hip fracture (N=96) and patients operated 
on after 24 hours (N=53) (P=0.62, Figure 5). Mortality rates were not signifi cantly diff erent 
between patients with and without post-operative delirium (P=0.37), nor between males 
and females (P=0.84). Fully independent patients had a signifi cantly lower mortality rate 
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Table 1. baseline characteristics of 149 patients with hip fractures
Gender (%)
men 17 (11,4) 
women 132 (88,6) 
Age (years) ± SD 93,5 ± 2,45
Charlson index score (%)
0 35 (23,5) 
1 52 (34,9) 
2 28 (18,8) 
3 20 (13,4) 
≥ 4 14 (9,4) 
ASA classification (%)
 ASA 2 36 (24,2) 
 ASA 3 104 (69,8) 
 ASA 4 9 (6,0)
Table 2. Type of fracture according different fracture classifications
Intracapsular
(n=16)
Pertrochanteric
(n=112)
Subtrochanteric
(n=21)
AO classification
 A1 40 
 A2 65 
 A3 7 21 
 B1 7 
 B2 7 
 B3 2 
Evans classification
 Type 1 13 
 Type 2 21 
 Type 3 13 
 Type 4 34 
 Type 5 31 
 Reversed type 21 
Pauwels classification
 Type 1 2 
 Type 2 7 
 Type 3 7 
Garden classification
 Type 1 5 
 Type 2 3 
 Type 3 6 
 Type 4 2 
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(P=0.011). The contribution of all these variables simultaneously, now also including the 
continuous variables age and length of hospital stay, to the Cox proportional hazards model 
was signifi cant (P < 0.0005), the signifi cant variables being ASA score, fully independent, 
length of hospital stay and age. The mortality rate ratio of ASA score 3 or 4 relatively to ASA 
score 2 was 1.9 (P = 0.017; 95 % CI: 1.1-3.3). Fully independent patients had a lower mortality 
rate than dependent patients (rate ratio 0.60; P= 0.027; 95 %CI: 0.38-0.94). A one-year age 
Increase resulted in a mortality rate ratio of 1.16 (P=0.001; 95 % CI: 1.06-1.26). A one-day 
longer hospital stay resulted in a mortality rate ratio of 1.03 (P=0.019; 95 % CI: 1.01-1.05). The 
P-values of the other variables in the model ranged from 0.36 to 0.73.
To determine the predictive value of these diff erent parameters on short-term mortality 
we measured mortality rates in only the fi rst three months, during which 34 deaths were 
observed. Univariate analyses using the log rank test showed that fully independent patients 
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had a lower short-term mortality rate (P=0.010) and that post-operative delirium was associ-
ated with a higher short-term mortality rate (P=0.019). Entering all variables simultaneously, 
now also including the continuous variables age and length of hospital stay, in the Cox pro-
portional hazards model led to a signifi cant eff ect on short-term mortality (P=0.013). The 
signifi cant variables were age (P=0.013) and length of hospital stay (P=0.030). A 1-year age 
increase and a 1-day longer stay in hospital resulted in short-term mortality rate ratios of 1.19 
(95 % CI: 1.04-1.37) and 1.03 (1.00-1.06), respectively. Fully independent patients had a lower 
short-term mortality (P=0.052; rate ratio 0.38; 95 % CI: 0.14-1.01). The eff ect of post-operative 
delirium was no longer signifi cant (P=0.16) as it was confounded with length of hospital stay. 
P-values of the other variables in the model ranged from 0.46 to 0.98.
Postoperative delirium was diagnosed in 49 (33%) patients. Median length of hospital stay in 
patients with postoperative delirium was 13 days against 9 days in patients without delirium 
(P=0.049).
Preoperatively, place of residence was the patients’ own home or a sheltered accommodation 
in 66 patients; only 20 (30%) of them returned to this place after surgery for hip fracture. The 
other 46 (70%) patients were discharged to a nursing or care home. Out of 39 patients preop-
eratively living in a nursing home, 16 (41%) returned to the nursing home after surgery and 
23 (59%) were discharged tot a care home. All patients living in a care home preoperatively 
(N=31) were discharged to a care home after surgery. In summery, 69 of 136 (51%) patients 
were discharged to a place with more care after undergoing osteosynthesis for a hip fracture 
(Table 3).
Regarding the consequences of a hip fracture on patient’s mobility we found the following 
results. Preoperative mobility was fully independent in 49 patients, but after surgery 44 (90%) 
patients needed a walking aid/frame, four (8%) patients ended up in a wheelchair, and only 
1 (2%) patient managed to walk fully independently. Seventy-fi ve patients used a walking 
aid/frame before their fracture. Postoperatively, 53 (71%) of them were mobile with the same 
Table 3. Place of residence before and after surgery for hip fracture
Post-operative
Own home Sheltered Nursing home Care home
Pre-operative
 Own Home (N=54) 16 (29,6%) 3 (5,6%) 8 (14,8%) 27 (50%) 
 Sheltered (N=12) 0 1 (8,3%) 4 (33,3%) 7 (58,3%) 
 Nursing home (N=39) 0 0 16 (41%) 23 (59%) 
 Care home (N=31) 0 0 0 31 (100%) 
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walking aid/frame, whereas the other 22 (29%) patients ended up in a wheelchair. The 3 
patients who were already in a wheelchair, remained as such after surgery. Thus, 70 of 124 
(57%) patients were less mobile after undergoing osteosynthesis of a hip fracture. (Table 4)
DISCUSSION
To our knowledge, this is the first study to describe the functional outcome and short-term 
and long-term mortality after osteosynthesis of a hip fracture in a large population of pa-
tients aged over 90 years. With the progressive increase in life expectancy and population 
growth, the incidence of hip fractures will increase in the near future.20 Advanced age, male 
gender, previous hospitalization, comorbidity, and other factors are known to be associated 
with increased morbidity and mortality and poor functional results after hip fracture.6,20 Yet, 
there is still no clear objective method for predicting the outcome of surgery in very elderly 
patients with hip fractures.
ASA classification and the CCI are both scoring systems for preoperative comorbidity. Burgos 
et al reported a relation between CCI and the development of serious complications during 
the hospital stay.20 In our study population with patients aged 90 years or older, mortality 
rates in patients with higher ASA scores were significant higher in comparison to those with 
lower ASA scores. On the other hand, CCI was not found to be predictor for mortality. Earlier 
studies already described a nine times increased risk for mortality in patient with high ASA 
scores (3 or 4).20,21 Therefore, ASA classification also seems the best predictive indicator for 
overall mortality after osteosynthesis of hip fractures in extremely elderly patients.
Because of the relative short life expectancy of extremely elderly patients it is interesting to 
look at the predictive value of risk factors on short-term mortality. An earlier study described 
exceptionally high mortality rates in the first 3 months after hip fracture.22 Indeed, our study 
showed a mortality rate of 23% in the first three months after surgery. However, we could not 
find a clear relationship between CCI scores, ASA scores, type of anesthesia, or total preopera-
Table 4. Patient’s mobility before and after surgery for a hip fracture
Post-operative
No aids One aid Walking frame Wheelchair
Pre-operative w
 No aids (N=49) 1 (2%) 3 (6,1%) 41 (83,7%) 4 (8,2%) 
 One aid (N=6) 0 0 4 (66,7%) 2 (33,3%) 
 Walking frame (N=69) 0 0 49 (71%) 20 (29%) 
 Wheelchair (N=3) 0 0 0 3 (100%) 
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tive delay and the 3-months mortality rate. Given the fact that the total preoperative delay 
did also not infl uence the long-term mortality, this suggest that patient’s general conditions 
can possibly be optimized before surgery. De Palma et al earlier described similar results with 
a preoperative delay of 48 hours.23 They concluded that patients with comorbidity conditions 
requiring stabilization do not necessarily need to be treated within 48 hours.
Delirium is a common complication in elderly patients after hip fracture surgery and is 
associated with adverse outcomes, including longer length of hospital stay, greater rate 
of institutional placement, greater dependence on others, higher costs, delayed recovery, 
and increased mortality.24 In our study, length of hospital stay was signifi cantly longer in 
patients with delirium. A longer length of stay was associated with higher short-term mortal-
ity, adjusted for delirium and other variables. Vochteloo et al described an integrated hip 
fracture care pathway that included a Risk Model for Delirium (RD) score.25 They concluded 
RD score was an accurate tool for identifying high-risk patients with poorer outcome regard-
ing delirium incidence, length of hospital stay, and return to pre-fracture living situation.25 
Wagner et al found a small benefi t of geriatric intervention in elderly patients operated on for 
a hip fracture, which was mainly demonstrated in improved and earlier detection of medical 
geriatric conditions such as anemia and delirium.26 Because of the poorer outcome measure-
ments in patients with postoperative delirium, it remains important to diagnose and treat a 
delirium in an early stage.
This study shows the loss of independency of extremely elderly persons after a hip fracture. 
Although many of these persons already have diffi  culties in walking and independent living, a 
large proportion of these patients are faced with defi nitive loss of independence.5 More than 
half of the patients were discharged to a place with more care after undergoing osteosyn-
thesis of a hip fracture and 57% of patients were less mobile after surgery. Fully independent 
patients had signifi cant lower mortality rates. Maybe in some cases, conservative treatment 
can be an alternative to surgery. However, this decision should be based on the individual 
patient and depends on several factors. Quality of life is an important factor in this decision 
and therefore it’s recommended to study quality of life in further research
CONCLUSIONS
As the general population is ageing, an increasing number of extremely elderly patients will 
suff er from hip fractures. Our study shows that short-term mortality rates in these patients 
are high and there is no clear predictive value for mortality. ASA classifi cation is the best 
predictive value for overall mortality in these patients. Finally, there is loss of independency 
in a large proportion of these patients after undergoing osteosynthesis of a hip fracture.
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GENERAL DISCUSSION
From a medical perspective the demographic shift towards a population with more older 
people forces us to reconsider health outcome measurements related to surgical procedures. 
In the older population the results of surgical treatment of vascular and orthopaedic trauma 
related diseases are not straightforward. Adequate patient selection may be the key to im-
prove treatment results of vascular and orthopaedic trauma related diseases in the elderly 
population balancing between the pros and contras of a surgical intervention.
Chapter 2 describes results from a retrospective study on patency rates of primary au-
tologous radio-cephalic arteriovenous fi stulae and brachio-cephalic arteriovenous fi stulae 
in patients aged 75 years and older. The Dialysis Outcomes Quality Initiative recommends 
radio-cephalic arteriovenous fi stulae before brachio-cephalic arteriovenous fi stulae in all 
dialysis patients needing hemodialysis.(1,2,3) However, our study shows brachio-cephalic 
arteriovenous fi stulae having a signifi cant higher primary and assisted patency and also 
signifi cant higher secondary patency rates at 1 and 2 years. Based on these results, we advo-
cate placement of fi stulae in the elbow in case of older people as a longer intervention-free 
and thrombosis-free interval time may off er clear benefi ts. Next to patency rates, another 
key outcome measure in the elderly is the Quality of life (QoL), which is increasingly being 
evaluated for other vascular interventions.(4) It is stated that elderly dialysis patients would 
be better able to deal with their disease and dialysis.(5,6) In this study, QoL of the older dialysis 
patient did not diff er greatly when compared to the QoL of elderly persons from the general 
population and patients after peripheral bypass surgery, as we demonstrated.(7,8) Thus these 
elderly dialysis patients, in which survival was poor, seems to maintain a relative high QoL 
despite the discomforts of dialysis. A disadvantage of our study is the retrospective design, 
giving a bias in the measurement of QoL. A prospective trial is needed to determine QoL in 
these dialysis patients.
Another vascular procedure is bypass surgery, which is performed in critical limb ischemia. 
At the moment, little is known about the outcome of this treatment in elderly patients. The 
treatment of critical limb ischemia in elderly patients was examined in chapter 3. We ana-
lyzed treatment results of elderly patients with critical limb ischemia (Rutherford 4 or 5/6) and 
divided the study population in two age groups (70-79 and 80+). In patients aged 80 years 
or older, surgical revascularization resulted in a signifi cant higher mortality rate, whereas 
primary conservative, endovascular treatment and amputation resulted in similar mortality 
in comparison with people aged 70-79 years. We conclude that surgical revascularization is a 
very high-risk procedure in patients aged 80 years and older with critical limb ischemia with 
a perioperative mortality of 22%. In contrast conservative management in these patients 
resulted in a perioperative mortality of 9%. Therefore, the surgeon should focus on careful 
patient selection when considering surgical revascularization in the very elderly. The defi ni-
tion of critical limb ischemia is important in this matter. Critical limb ischemia with limited 
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tissue loss or pain can be managed conservatively in the non-ambulant elderly, whereas 
severe tissue loss in patients with a vascular lesion unsuitable for endovascular treatment 
represents the other end of the spectrum. More attention should be paid to QoL in addition 
to surgical feasibilities. Patients with critical limb ischemia have poor health prospects and 
life expectancy, irrespective of treatment administered.(9) Randomized trials of health-related 
Quality of life after revascularization versus primary amputation are nonexistent and the 
available observational studies do not allow sound conclusions, due to small numbers and 
methodologic imperfections.(9) In this study, primary amputation in patients with critical limb 
ischemia resulted in better survival as compared to surgical revascularization. However, what 
this means for the quality of life in these patients is yet not clear. For this reason, recently a 
prospective study was started in the Amphia hospital, Breda, The Netherlands. This study 
focuses on the quality of life before, during and after treatment of critical limb ischemia in 
elderly patients.
In Chapter 4 a review of the literature concerning treatment of AAA in elderly patients 
is presented in addition to our results on the elective treatment of abdominal aorta an-
eurysms (AAA) in elderly patients. Geisbusch et al. described that endovascular aneurysm 
repair (EVAR) in octogenarians had acceptable midterm survival rates and suggested that 
age should therefore not be an exclusion criteria for EVAR.(10,11) Also, in “high risk” patients 
EVAR for AAA was justified with a 2-year survival rate of 84%.(12) Our study demonstrates 
that mortality after endovascular treatment of AAA in patients aged 80 years and older was 
significantly higher compared to the younger group. Morphology of AAA was not described 
in our study and could have influenced this outcome. It may be argued that patients aged 80 
years and older were treated with EVAR despite of more difficult morphology of AAA. These 
patients may present with more comorbidity and the outcome may be biased as EVAR is 
less invasive than OPEN repair, thus favouring a minimal invasive approach. This assumption 
is supported by the fact that a relative small number of patients aged 80 years and older 
underwent OPEN repair. Schlösser et al. reported a 1-year mortality rate after elective OPEN 
surgical AAA repair of 33% in patients aged 80-84 years and 54% in patients aged above 
85 years.(13) In comparison, our study showed a 1-year mortality rate of 17% after elective 
EVAR in octogenarians. Therefore, EVAR in patients aged 80 years and older seems to have 
acceptable survival, despite the significantly higher mortality rate in comparison to younger 
patients. Conservative management of AAA was investigated and significantly higher mortal-
ity rates after conservative management of AAA were found as compared to EVAR or OPEN 
repair. However, after conservative management of AAA 38% of patients aged 80 years or 
older were still alive after 5-year follow up against 60% after EVAR and 87% OPEN repair. 
The definition of AAA is important in this matter and asymptomatic aneurysms of the aorta 
with diameters equal to or slightly larger than the treatment criteria can more easily be man-
aged conservatively. One article of our review reported on the conservative management 
of AAA in “high risk” patients unfit for surgery and concluded that aneurysm rupture rate is 
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relatively high among conservatively treated patients unfi t for surgery. In this conservative 
treated group of patients, 42% survived the operation of a ruptured AAA. Despite of the fact 
that conservative management of AAA results in higher mortality, it should be an option in 
patients with poor general health and signifi cant comorbidities.
In chapter 5 we performed a secular trend analysis of all hospitalizations due to a pelvic 
fracture among older adults, using the National Medical Registration, 1986-2011, the Neth-
erlands. The total number of hospitalizations due to a pelvic fracture increased from 887 in 
1986 to 2,013 admissions in 2011 (127% increase). The overall age-adjusted incidence rate 
increased from 5.19 in 1986 to 7.14 per 10,000 population in 2011 (37.5% increase). The mean 
length of hospital stay decreased from 25.8 to 12.0 days between 1991 and 2011 (53.4% 
decrease). Absolute numbers and incidence rates of pelvic fractures are increasing among 
the older Dutch population. Attention on osteoporosis screening and prevention of falls in 
elderly remains important, in order to limit related healthcare costs in the future.
In Chapter 6 our results of operative treatment for proximal fractures of the humerus in 
elderly patients (> 75 years) are presented. Sixty-four patients were treated surgically for a 
displaced proximal fracture of the humerus, 15 two-part, 32 three-part and 17 four-part frac-
tures. Regarding the operative methods, overall good results were obtained with the modern 
locked plate osteosynthesis. Persistent pain and ADL-limitations were more present in more 
comminuted fractures (64% and 50% in patients with 4-part fractures vs 14% in patients with 
2-part fractures). Especially in patients treated by locked compression plates, adequate pain 
reduction and functional recovery was achieved In the studied population, pain experience, 
ADL limitations and the overall functional outcome as measured by the DASH score, is signifi -
cantly worse after hemiarthroplasty compared to internal fi xation. In this study we conclude 
that it is safe and justifi able to perform osteosynthetic repair of a severely dislocated proximal 
humerus fracture in selected patients of 75 years and older. Surgery of the proximal humerus 
fracture might diminish pain and ADL limitations and potentially contribute to the preserva-
tion of an independent lifestyle.
Chapter 7 describes the outcome after osteosynthesis of hip fractures in nonagenarians. 
Short-term survival was 91% and 77% on 30-day and 3-months respectively. Long-term 
survival was 64%, 42% and 18% at 1-, 3- and 5 years after surgery. The overall one-year 
mortality rate associated with hip fracture is reported between 14% to 47%.(14,15) Following 
these numbers, it seems justifi ed to perform surgery for a hip fracture in extremely elderly pa-
tients. In order to demonstrate predictive value of comorbidities for mortality patients were 
stratifi ed according ASA and Charlson comorbidity index (CCI) score. Survival was signifi cant 
better in patients with lower ASA score (P<0,05). The study further shows that short-term 
mortality rates in these patients are relatively high and there is no clear predictive value. 
ASA classifi cation is the best predictive value for overall mortality in these patients. CCI score 
was not of predictive value for mortality. This study confi rms the loss of independency of 
extremely elderly persons after a hip fracture. Although many of these persons already have 
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difficulties in walking and independent living, a large proportion of these patients are faced 
with definitive loss of independence. More than half of the patients were discharged to a 
place with more care after undergoing osteosynthesis of a hip fracture and 57% of patients 
were less mobile after surgery. These results are probably of influence on the quality of life 
in these patients and therefore further studies on the different aspects of quality of life are 
recommended.
FUTURE PERSPECTIVES
In these studies the presence of delirium was not examined. However, delirium is a serious 
comorbidity in the elderly population. It is well known that presence of a delirium results 
in a significantly higher morbidity and mortality after surgical treatment in general. Further 
studies on surgical treatment in the very elderly should pay attention to the presence of 
delirium to assess the influence on survival, morbidity and independency of these patients.
Nevertheless, a close cooperation between surgeon and geriatrician in the treatment of 
these patients is to recommend.
Other important outcome measurements that should get more attention in further stud-
ies of the elderly population are decubitus, nutrition and physical condition. Pre-operative 
nutrition level and physical condition of patients can seriously influence the outcome after 
surgical interventions. Decubitus is a common problem in (especially) older patients that can 
cause serious comorbidity, decline in quality of life and even loss of independency.
CONCLUSIONS
This thesis shows that the elderly population is a very specific group of patients whose treat-
ment is not straightforward, but must be tailored to the individual patient. It remains difficult 
to express comorbidity in a specific score, and thereby predicting the risk of dying as a result 
of a certain operation. For the future, development of a better tool to assess mortality of 
surgical treatment is recommended. In general, the impact of surgical treatment on quality 
of life in these elderly patients needs more attention. In order to assess outcome of different 
treatment strategies, quality of life and general condition of patients must be taken into ac-
count.
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ALGEMENE DISCUSSIE EN SAMENVATTING
De demografi sche verschuiving in het aantal ouderen zorgt voor een oudere behandelgroep. 
De chirurgische behandeling van vasculaire en trauma gerelateerde aandoeningen in deze 
oudere populatie is niet eenvoudig. Zorgvuldige patiëntselectie zou wel eens de sleutel kun-
nen zijn tot betere behandelresultaten van vasculaire en trauma gerelateerde aandoeningen 
binnen deze oudere bevolkingsgroep.
Hoofdstuk 2 beschrijft de resultaten uit onze retrospectieve studie naar patency waardes 
van primaire autologe radio-cefale arterioveneuze fi stels en brachio-cefale arterioveneuze 
fi stels bij patiënten van 75 jaar en ouder. De Dialysis Outcomes Quality Initiative adviseert 
het aanleggen van radio-cefale arterioveneuze fi stels boven brachio-cefale arterioveneuze 
fi stels in alle hemodialyse patiënten. (1,2,3) Echter, onze studie bij oudere patiënten toont aan 
dat brachio-cefale arterioveneuze fi stels een signifi cant hogere primaire en assisted patency 
hebben en tevens ook een signifi cant hogere secondaire patency na 1 en 2 jaar. Gezien het 
langere interventie-vrije en trombose-vrije interval pleiten wij voor het aanleggen van een el-
leboogfi stel bij deze oudere patiëntenpopulatie. Naast deze patency waardes, is de kwaliteit 
van leven binnen de ouderenzorg een steeds belangrijkere uitkomstmaat, welke ook steeds 
vaker wordt geëvalueerd bij andere vasculaire interventies. (4) Bejaarde dialyse patiënten 
zouden daarbij beter kunnen omgaan met hun ziekte en het dialyseren. (5,6) In deze studie, 
is er weinig verschil tussen de gemeten kwaliteit van leven van de oudere dialyse patiënt 
in vergelijking met de kwaliteit van leven gemeten bij ouderen uit de algemene populatie 
en patiënten na perifere bypass chirurgie, zoals enkele eerdere studies hebben aangetoond. 
(7,8) Dus deze populatie van oudere dialysepatiënten, waarin de overleving slecht is, lijkt een 
relatief hoge kwaliteit van leven te ervaren ondanks de ongemakken van dialyse. Het blijft 
echter moeilijk om de kwaliteit van leven retrospectief te meten en prospectief onderzoek 
is daarom ook nodig om de kwaliteit van leven beter te kunnen bepalen in deze dialysepa-
tiënten.
Een andere vasculaire procedure is bypass chirurgie, hetgeen kan worden uitgevoerd in 
het geval van kritieke ischemie van de onderste extremiteit. Op dit moment is nog weinig 
bekend over de resultaten van deze behandeling bij ouderen. De behandeling van kritieke 
extremiteiten ischemie bij ouderen wordt beschreven in hoofdstuk 3. We analyseren de 
behandelresultaten bij oudere patiënten met kritieke ischemie van de onderste extremiteit 
(Rutherford 4 of 5/6) en verdelen de studie populatie in twee leeftijdsgroepen (70-79 en 80). 
Bij patiënten van 80 jaar of ouder resulteert bypass chirurgie in een signifi cant hogere mor-
taliteit. Daarentegen leidt primaire conservatieve, endovasculaire behandeling en amputatie 
tot vergelijkbare sterfte binnen beide leeftijdsgroepen. We kunnen concluderen dat bypass 
chirurgie een zeer risicovolle procedure is bij patiënten van 80 jaar en ouder met kritieke 
ischemie met een perioperatieve sterfte (30-dagen mortaliteit) van 22 %. In vergelijking 
leidt conservatieve behandeling in deze patiënten tot een 30-dagen mortaliteit van 9 %. 
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De chirurg moet zich dus concentreren op een zorgvuldige patiëntselectie wanneer bypass 
chirurgie wordt overwogen bij de hoogbejaarden. De definitie van kritieke ischemie is hierbij 
wel van belang. Kritieke ischemie met een beperkte wonden of pijn kan vaak conservatief 
worden behandeld in de niet-ambulante ouderenzorg, terwijl in het geval van ernstige 
wonden met veel pijn bij patiënten met vasculaire laesies die niet geschikt zijn voor endo-
vasculaire behandeling vaak chirurgische interventie is aangewezen. Kwaliteit van leven is 
een belangrijke uitkomst van de behandeling. Patiënten met kritieke ischemie hebben, on-
geacht de gekozen behandeling, slechte vooruitzichten met betrekking tot gezondheid en 
levensverwachting. (9) Gerandomiseerde trials naar gezondheids-gerelateerde kwaliteit van 
leven na chirurgische revascularisatie versus kwaliteit van leven na primaire amputatie zijn er 
nog niet en de beschikbare observatiestudies geven geen duidelijke uitkomsten, als gevolg 
van kleine aantallen en methodologische onvolkomenheden. (9) In deze studie, resulteert 
primaire amputatie bij patiënten met kritieke ischemie in betere overleving in vergelijking 
tot wanneer er chirurgische revascularisatie wordt verricht. Echter, wat dit betekent voor de 
kwaliteit van leven van deze patiënten is nog niet duidelijk. Om die reden is onlangs een 
prospectieve studie gestart in het Amphia ziekenhuis, Breda. Deze studie richt zich op de 
kwaliteit van leven voor, tijdens en na de behandeling van kritieke ischemie van de onderste 
extremiteit bij ouderen.
In hoofdstuk 4 worden de resultaten van electieve behandeling van een aneurysma van de 
abdominale aorta (AAA) bij ouderen beschreven. Tevens is er een overzicht van de literatuur 
over de behandeling van AAA in oudere patiënten. Geisbusch et al. beschreven dat de endo-
vasculaire behandeling van een abdominaal aneurysma (EVAR) bij tachtigjarigen aanvaard-
bare overlevingsgetallen liet zien en suggereerde dat leeftijd daarom geen exclusiecriteria 
mag zijn voor EVAR. (10,11) Ook in “hoog risico” patiënten was EVAR gerechtvaardigd met een 
2-jaars overleving van 84 % . (12) Onze studie toont aan dat de mortaliteit na endovasculaire 
behandeling van een AAA bij patiënten ouder dan 80 jaar significant hoger was in vergelij-
king met de jongere groep. Morfologie van een AAA is echter niet beschreven in onze studie 
en zou invloed kunnen hebben gehad op dit resultaat. Het is namelijk mogelijk dat patiënten 
van 80 jaar en ouder werden behandeld met EVAR ondanks morfologische kenmerken van 
een AAA die deze procedure lastiger maken. Er kan een selectie bias zijn opgetreden als deze 
patiënten met meer co morbiditeit werden behandeld middels EVAR, omdat dit een minder 
invasieve ingreep is. Deze veronderstelling wordt ondersteund door het feit dat een relatief 
klein aantal patiënten van 80 jaar en ouder een open procedure van een AAA ondergingen. 
Schlösser et al. beschreven een 1-jaars mortaliteit van 33% na electieve open behandeling 
van een AAA bij patiënten van 80 tot 84 jaar en 54% bij patiënten ouder dan 85 jaar. (13) Ter 
vergelijking, is de 1-jaars mortaliteit na electieve EVAR bij tachtigjarigen in onze studie 17%. 
Gezien deze verschillen in mortaliteitpercentages lijkt het verrichten van een EVAR bij patiën-
ten ouder dan 80 jaar aanvaardbaar, ondanks de aanzienlijk hogere sterfte in vergelijking met 
jongere patiënten. Wanneer de conservatieve behandeling van een AAA wordt onderzocht, 
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zien we aanzienlijk hogere sterftecijfers na conservatieve behandeling van een AAA in verge-
lijking met mortaliteit na EVAR of open behandeling. De 5-jaars overleving van conservatieve 
behandeling van een AAA bij patiënten ouder dan 80 jaar was 38% in vergelijking met 60% 
na EVAR en 87% na open behandeling. De defi nitie van een AAA is hierbij belangrijk, omdat 
een asymptomatische aneurysma van de aorta met een diameter gelijk aan of iets groter dan 
de behandeling criteria gemakkelijker conservatief behandeld kan worden. Een artikel uit 
onze review beschrijft de conservatieve behandeling van een AAA in “hoog risico” patiënten 
die niet fi t genoeg waren om een chirurgische behandeling te ondergaan. Er wordt gecon-
cludeerd de ruptuurkans van een AAA binnen deze conservatief behandelde patiëntengroep 
relatief hoog ligt, maar dat daarentegen 42 procent van deze patiënten de operatie van het 
geruptureerde aneurysma uiteindelijk hebben overleeft. Ondanks het feit dat conservatieve 
behandeling van een AAA resulteert in hogere mortaliteit, zou het dus een optie kunnen zijn 
bij patiënten met een slechte algemene gezondheid en belangrijke co morbiditeit.
In hoofdstuk 5 voeren we een trend analyse uit van alle ziekenhuisopnames als gevolg 
van een bekkenfractuur bij oudere patiënten. We maken hierbij gebruik van de Nationale 
Medische Registratie, 1986-2011, Nederland. Het totaal aantal ziekenhuisopnames ten ge-
volge van een bekkenfractuur steeg van 887 in 1986 naar 2.013 opnames in 2011 (127% 
stijging). De totale voor leeftijd gecorrigeerde incidentie steeg van 5,19 in 1986 tot 7,14 per 
10.000 inwoners in 2011 (37,5 % toename). De gemiddelde duur van een ziekenhuisverblijf is 
tussen 1991 en 2011 afgenomen tot 12,0 dagen (53.4% afname). Absolute aantallen en inci-
dentie van bekkenfracturen nemen toe bij de oudere Nederlandse bevolking. Aandacht voor 
osteoporose screening en preventie van vallen bij ouderen blijft belangrijk om gerelateerde 
kosten voor de gezondheidszorg in de toekomst te reduceren.
In hoofdstuk 6 worden de resultaten van operatieve behandeling van proximale hu-
merusfracturen bij oudere patiënten (> 75 jaar) besproken. Vierenzestig patiënten werden 
behandeld voor een gedisloceerde proximale humerusfractuur, waarvan 15 two-part, 32 
three-part en 17 four-part fracturen. Er werden goede resultaten bereikt met de moderne 
vergrendelplaat osteosynthese. Persisterende pijnklachten en ADL-beperkingen zijn meer 
aanwezig in meer communitieve fracturen (64% en 50% bij patiënten met een 4-part fractuur 
versus 14% bij patiënten met een 2-part fractuur). Met name bij de patiënten behandeld 
met open repositie en interne fi xatie middels vergrendelde compressieplaten werd adequate 
pijnvermindering en functioneel herstel bereikt In de bestudeerde populatie. Pijn beleving, 
ADL beperkingen en het algehele functionele resultaat zoals gemeten met de DASH score 
waren beduidend slechter na een schouderkopprothese in vergelijking met open repositie 
en interne fi xatie. Deze studie concludeert dat het veilig en verantwoord is om een os-
teosynthese van een ernstig gedisloceerde proximale humerusfractuur te verrichtten bij 
geselecteerde patiënten van 75 jaar en ouder. Chirurgische behandeling van een proximale 
humerusfractuur kan zorgen voor verminderde pijn en ADL beperking en mogelijk bijdragen 
tot de instandhouding van een onafhankelijk leven.
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Hoofdstuk 7 beschrijft het resultaat na osteosynthese van heupfracturen bij 90-plussers. 
Korte-termijn overleving was respectievelijk 91% en 77% op 30-dagen en 3-maanden. Lange 
termijn overleving was respectievelijk 64 %, 42% en 18% op 1-, 3- en 5 jaar na operatie. De 
totale jaarlijkse sterfte geassocieerd aan een heupfractuur wordt beschreven tussen de 14% 
en 47%. (14,15) Aan de hand van deze getallen lijkt chirurgie gerechtvaardigd bij hoogbejaarde 
patiënten met een heupfractuur. Om de voorspellende waarden van diverse co mobiliteiten 
te bepalen werden patiënten gescoord volgens de ASA en Charlson comorbidity index (CCI) 
score. De overleving was significant beter in patiënten met lagere ASA score (P<0,05 ). Uit 
de studie blijkt verder dat de korte-termijn sterfte in deze patiënten relatief hoog is en dat 
er geen duidelijk voorspellende waarde is voor sterfte. ASA classificatie is de beste voorspel-
lende waarde voor de totale sterfte in deze patiënten. CCI score was niet van voorspellende 
waarde voor de sterfte. Deze studie toont aan dat een heupfractuur bij hoogbejaarde per-
sonen grote impact heeft op de mate van onafhankelijk van deze populatie. Hoewel veel 
van deze personen al moeilijkheden ervaren met lopen en hun zelfstandigheid, wordt een 
groot deel van deze patiënten geconfronteerd met een definitief verlies van hun zelfstandig-
heid. Meer dan de helft van de patiënten werden na het ondergaan van osteosynthese een 
heupfractuur ontslagen naar een instelling met meer zorg en 57% van de patiënten waren 
minder mobiel. Deze resultaten hebben waarschijnlijk invloed op de kwaliteit van leven van 
deze patiënten, maar in welke mate zal verder onderzoek hiernaar moeten aantonen.
TOEKOMSTPERSPECTIEVEN
In deze onderzoeken is de incidentie van een delier niet onderzocht. Echter, delier is een 
ernstige co morbiditeit voor de oudere patiëntenpopulatie. Het is bekend dat de aanwezig-
heid van delier resulteert in een beduidend hogere morbiditeit en mortaliteit na chirurgi-
sche behandeling in het algemeen. Verdere studies naar de chirurgische behandeling van 
ouderen zullen aandacht moeten besteden aan de aanwezigheid van delier ter beoordeling 
van de invloed hiervan op de overleving, morbiditeit en mate van zelfstandigheid van deze 
patiënten. Een nauwe samenwerking tussen chirurg en geriater in de behandeling van deze 
patiënten wordt aangeraden. Andere belangrijke uitkomstmaten die meer aandacht verdie-
nen in toekomstige studies met betrekking tot ouderen zijn decubitus, voeding en algemene 
fysieke conditie. Preoperatieve voedingstoestand en de fysieke conditie van patiënten kun-
nen van grote invloed zijn op de uitkomst van chirurgische behandelingen. Decubitus is een 
veelvoorkomend probleem in (vooral) oudere patiënten, hetgeen kan leiden tot ernstige co 
morbiditeit, achteruitgang in kwaliteit van leven en zelfs verlies van zelfstandigheid.
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CONCLUSIE
Dit proefschrift toont aan dat de oudere patiëntenpopulatie een zeer specifi eke groep 
patiënten is, waarvan de behandeling niet eenvoudig is en moet worden afgestemd op de 
individuele patiënt. Het blijft moeilijk om co morbiditeit uit te drukken in een specifi eke score 
en zodoende te voorspellen wat het sterfterisico is van een bepaalde behandeling. De ont-
wikkeling van een beter instrument voor het inschatten van het sterfterisico van chirurgische 
behandeling is aanbevolen. Verder is er in het algemeen meer aandacht nodig voor het eff ect 
van chirurgische behandeling op kwaliteit van leven van de oudere patiëntpopulatie. Om 
resultaten van verschillende behandelingsstrategieën te kunnen beoordelen, moet aandacht 
zijn voor de kwaliteit van leven en de algemene conditie van patiënten.
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DANKWOORD 
Het schrijven van een proefschrift vergt veel van een promovendus. Promoveren gedurende 
je opleiding tot chirurg is niet alleen voor de promovendus een uitdaging, maar vraagt ook 
om heel veel begrip, medewerking en met name vertrouwen vanuit zijn omgeving. Daarom 
wil ik een ieder die heeft bijgedragen aan de totstandkoming van dit proefschrift enorm 
bedanken, waarbij natuurlijk een aantal personen in het bijzonder…
Professor dr. J.N.M. IJzermans, dankzij uw vertrouwen in mij is het mogelijk geweest om 
mijn onderzoeksresultaten te kunnen bundelen tot dit proefschrift. Daarvoor ben ik u zeer 
dankbaar. Na uw bijdrage aan dit proefschrift kijk ik dan ook erg uit naar uw bijdrage aan mijn 
opleiding tot chirurg.
dr. L. van der Laan, als arts-assistent chirurgie kwam ik werken in het Amphia ziekenhuis. Toen 
ik vervolgens bij u kwam en vertelde dat ik toch echt de ambitie had om chirurg te worden, 
begon u over het belang van het doen van wetenschappelijk onderzoek. In eerste instantie 
was dit zeker niet iets wat ik ambieerde, maar u wist me te overtuigen en enthousiast te 
maken voor deze “tak van sport”. En na een moeizaam begin kunnen we concluderen dat 
dit zijn vruchten heeft afgeworpen en heeft geleid tot een mooi proefschrift. Zonder uw 
gedrevenheid, support en vaak “onmogelijke” deadlines was dit nooit gelukt. Daarvoor wil 
ik u enorm bedanken. Ook binnen mijn opleiding tot chirurg zal u in de toekomst nog een 
belangrijke rol gaan spelen en ik heb er alle vertrouwen in dat ik ook in deze fase weer op u 
kan rekenen!
Geachte leden van de leescommissie, prof.dr. H.J.M. Verhagen, prof.dr. P. Patka en prof.dr. 
M.H.J. Verhofstad, heel hartelijk dank voor het kritisch beoordelen van mijn proefschrift en 
het zitting nemen in de oppositie.
Tevens dank ik prof.dr. E.W. Steyerberg, prof.dr. H.J. Stam en dr. F.U.S. Mattace Raso voor hun 
zitting als opponent in de promotiecommissie.
Beste chirurgen van het Amphia ziekenhuis, als beginnend arts heb ik al van jullie mogen 
leren. Nu ik mijn opleiding grotendeels in het Amphia mag doen, zal onze samenwerking 
alleen maar intensiever worden. Ik heb er alle vertrouwen in dat ik me met behulp van jullie 
steun en begeleiding kan ontwikkelen tot een goede chirurg.
Beste chirurgen van het Reinier de Graaf ziekenhuis, bedankt voor de leerzame en ook zeker 
gezellige tijd in Delft.
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Beste secretaresses, Beste Jacqueline, Beste Carola, dank voor jullie hulp bij de vele dingen 
die geregeld moesten worden gedurende het schrijven van dit proefschrift.
Beste co-auteurs, jullie bijdrage aan dit proefschrift spreekt voor zich. Bedankt!
Beste assistenten “Amphia” en “Reinier”, in ons dynamische vak is collegialiteit wat mij betreft 
een van de belangrijkste eigenschappen. Bij jullie heb ik daarover nooit te klagen gehad en 
daar ben ik jullie erg dankbaar voor.
Beste voetbalvrienden, Na een lange dag in het ziekenhuis is het heerlijk om even samen 
met jullie achter een bal aan te rennen en daarna een biertje te drinken aan de bar. En ook al 
word ik volgens sommige van jullie inmiddels een ouwe lul, ik hoop nog zeker een paar jaar 
met jullie mee te kunnen.
Beste vrienden, het schrijven van dit proefschrift is grotendeels gebeurt in mijn “vrije” tijd. Dit 
betekende dat wij elkaar minder zagen dan voorheen. Nu dit proefschrift een feit is hoop ik 
weer vaker met jullie op stap te kunnen gaan!
Lieve paranimfen, Simone en Thanya,
Simone, jij leerde mij (nota bene als co-assistent) wat het werk van een zaalarts in het 
Amphia ziekenhuis betekende. Daarna zijn we collega’s geworden, maar vooral goede vrien-
den, en dat is me veel waard. Bedankt daarvoor, ik ben blij dat jij naast me staat tijdens mijn 
verdediging
Thanya, in mijn periode in Delft was jij bijna klaar met je opleiding tot chirurg. Je hebt 
me altijd enorm geholpen met het bereiken van mijn doel: aangenomen worden voor de 
opleiding tot chirurg. Fantastisch dat dit uiteindelijk is gelukt en dank voor je hulp hierbij. 
Verder natuurlijk dank voor je dierbare vriendschap en je steun tijdens mijn verdediging.
Lieve schoonouders, lieve Kees en Willy en lieve schoonzus, lieve Bianca, vanaf het moment 
dat ik bij jullie over de vloer kwam voelde het als thuis. Dank voor jullie steun en liefde.
Lieve Opa en Oma, wat leuk dat jullie dit nog allemaal mee kunnen maken. Het is fijn om 
zulke grootouders te hebben. En natuurlijk bedankt voor jullie medewerking aan de kaft van 
dit proefschrift!
Lief zusje, lieve Joyce, vaak stond je onbedoeld in mijn schaduw, iets waar ik me altijd erg aan 
heb gestoord. Jij hebt inmiddels ruimschoots bewezen wat je allemaal kan en ik ben enorm 
trots op je! Beste Stefan, heb er alle vertrouwen in dat jij goed voor mijn zusje zorgt!
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Lieve Pa en Ma, wat heb ik toch geluk met zulke ouders. Altijd staan jullie voor ons klaar. Jullie 
liefde, steun en vertrouwen is altijd onvoorwaardelijk. Hoe jullie je “taak” als Opa en Oma 
invullen, maakt me trots! Ik hou van jullie!
Lieve schatten, Lieve Sabine en Tess, jullie zijn mijn alles. Tijdens het schrijven van dit proef-
schrift heb ik veel van jullie gevraagd, maar altijd steunden jullie me. Ik kijk uit naar alle mooie 
momenten die wij in de toekomst nog met elkaar gaan beleven! Ik hou van jullie!
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